10:00 AM – 4:00 PM
Endocrine Surgical Section Review of Endocrine Surgical Advancements Course
This session is supported by a generous educational grant from Medtronic.
10:00 AM – 11:00 AM
Instructional Courses (Concurrent Sessions)
Instructional Course 01: How to Improve the Patient Experience
Moderator: Carol Lewis
This panel discussion will focus on what falls under the umbrella of patient experience, from institutional to department programming, highlighting the interconnectedness of the modern medical center. Speakers will describe the different aspects of patient experience with an emphasis on creating a culture of value-based commitment with patient experience at its core.
At the conclusion of this session, participants will be able to:
- Recognize the contemporary scope of patient experience, from access to and coordination of care through the continuum of treatment and inclusive of patient advisory committees and resources, that is reflected in evaluations of hospitals and individual providers.
- Understand the importance of patient experience in an era of rising consumerism in health care.
- Demonstrate how patient experience data can drive quality improvement projects and, on an individual level, improve provider and care team communication with patients.
10:00 AM | Patient Experience: What’s Involved and How to Improve It | Carol Lewis |
10:25 AM | Patient Experience in an Era of Rising Consumerism in Healthcare | Brian Moore |
10:50 AM | Q&A |
Instructional Course 02: Social Media in Head and Neck Practice
Moderator: Arvind Badhey
We will use an open forum format facilitated by panelists to stimulate audience discussion regarding effective and safe use of social media as an oncologic surgeon. We will also provide an update on social media use as it pertains to medicine & HIPAA. In addition we will provide examples and poll the audience regarding meaningful and appropriate use of a variety of platforms.
At the conclusion of this session, participants will be able to:
- Assess and compare the variety of social media platforms that exist.
- Determine which is most appropriate for use by the oncologic surgeon.
- Discuss and describe examples of meaningful and safe utilization of social media
10:00 AM | Choose Your Platform | Arvind Badhey |
10:05 AM | Audience Discussion | |
10:15 AM | Update on Safe & Appropriate Use | Alice Tang |
10:20 AM | Audience Discussion | |
10:25 AM | Examples of Posts | Elizabeth Cottrill |
10:30 AM | Audience Discussion | |
10:40 AM | Role of Social Media Summary | |
10:45 AM | What Can the Society Do? |
Instructional Course 03: Identifying Populations at Risk
Moderator: Thomas Ow
Risk stratification for patients with cancers of the head and neck region is generally underdeveloped – screening approaches are not well established, and accurate and clinically applicable means of identifying patients at highest risk of recurrence, metastasis, toxicity, and mortality are not available. This lecture will identify critical knowledge gaps, unmet needs, current concepts, and potential developments aimed at improving the diagnosis, surveillance and treatment for patients at highest risk of morbidity and mortality from cancers of the head and neck region.
At the conclusion of this session, participants will be able to:
- Identify populations of patients at greatest risk of developing or experiencing significant morbidity and/or mortality from cancers of the head and neck.
- Illustrate key knowledge gaps and unmet needs among current approaches toward the diagnosis and care delivery for patients at greatest risk of poor outcome from head and neck cancers.
- Appraise current and potential genomic and molecular biomarkers available for risk stratification among patients with cancers of the head and neck.
10:00 AM | Overview of Risk of Development and Progression of Head and Neck Cancers | Thomas Ow & Sean Massa |
10:02 AM | Social and Demographic Determinants of Development and Poor Outcome Among Patients with Head And Neck Cancer | Sean Massa |
10:22 AM | Social and Demographic Risk: Q&A | |
10:31 AM | Genomic and Molecular Biomarkers in Risk Stratification for Patients with Cancers of the Head and Neck: Recent Advances and Future Developments | Thomas Ow |
10:51 AM | Genomic and Molecular Biomarkers for Risk Assessment: Q&A |
Instructional Course 04: Decision Making in Advanced Laryngeal and Hypopharyngeal Cancer
Moderator: Melonie Nance
We will discuss evidence-based surgical and non-surgical management of advanced laryngeal and hypopharyngeal cancer. Topics will include: indications for upfront laryngectomy vs primary chemoradiation, surveillance and survivorship after treatment, neck dissection and reconstruction for salvage laryngectomy.
At the conclusion of this session, participants will be able to:
- Compare surgical and non-surgical treatment options and discuss indications in light of frailty.
- Describe indications for neck dissection and flap reconstruction during salvage laryngectomy.
- Implement surveillance and survivorship post treatment protocols for advanced laryngeal and hypopharyngeal cancer patients.
10:00 AM | T3/4 Larynx Cancer: To Operate or Not? | Melonie Nance |
10:15 AM | Surveillance/Survivorship After Treatment | Melonie Nance |
10:30 AM | Neck Dissection During Salvage Laryngectomy: Is it Required? | Kiran Kakarala |
10:45 AM | Reconstruction for Salvage Laryngectomy: Flap or No Flap?/Free Flap or Regional Flap? | Kiran Kakarala |
Instructional Course 05: Update in the Management of Biosphosphonate and Radiation Induced Osteonecrosis
Moderator: Brett Miles
Current management of maxillofacial osteonecrosis will be discussed from a medical and surgical perspective. Illustrative case based learning will be utilized with active audience participation and discussion. Radiation and Medication Related Osteonecrosis will be discussed.
At the conclusion of this session, participants will be able to:
- Differentiate the pathophysiology of osteoradionecrosis versus medication-related osteonecrosis of the jaw (MRONJ).
- Examine the use of hyperbaric oxygen for tissue salvage in osteoradionecrosis and including the appropriate regimen, and expected outcomes.
- Employ medical management strategies in osteoradionecrosis and MRONJ, and become familiar with dosing and administration.
10:00 AM | Introduction | Brett Miles |
10:05 AM | Case 1 – ORN | Rusha Patel |
10:20 AM | Case 2 – ORN | Heather Edwards |
10:35 AM | Case 3 – MRONJ | Brett Miles |
10:50 AM | Q&A |
Instructional Course 06: Update on Surgery for NMSC – Beyond WLE and Mohs
Moderator: Kevin Emerick
This session will describe the current techniques and possible future techniques for excising high risk and locally advanced skin cancers. We will utilize case discussions to highlight the key techniques and principles.
At the conclusion of this session, participants will be able to:
- Describe the principles of Complete Circumferential Peripheral and Deep Margin Assessment and the various types of techniques included in this type of assessment.
- Understand the strengths and weaknesses of various CCPDMA techniques.
- Understand some of the key biological behaviors and histopathologic features that can guide the use of improved surgical techniques.
10:00 AM | Introduction | Kevin Emerick |
10:05 AM | Principles of CCPMDA | Jessica Yesenski |
10:15 AM | Micrographic Mohs Surgery Basics | Vishal Patel |
10:25 AM | New Techniques for the Future | Kevin Emerick |
10:35 AM | Case Discussion |
Instructional Course 07: Virtual Planning for Mandible and Maxillary Reconstruction
Moderator: Alexandra Kejner
This will be a case-based, defect centered instructional course addressing the following topics: Maxillary reconstruction, mandibular reconstruction, management of dental implants/orbital contents, and pedicle and soft tissue management during planning; troubleshooting situations, pearls/pitfalls. We will also discuss atypical reconstructions including Iliac crest, OCRFF, soft tissue plus custom plates, jaw in a day.
At the conclusion of this session, participants will be able to:
- Articulate the various reconstructive options based on defect type, patient characteristics, and functional needs.
- Implement tips and tricks for optimizing their engineer’s expertise during reconstruction.
- Plan and formulate various reconstruction plans and options with maximum efficiency.
10:00 AM | Virtual Surgical Planning for Maxillary Reconstruction | Chad Zender |
10:15 AM | Virtual Surgical Planning for Mandibular Reconstruction | Byung Joo Lee |
10:30 AM | Virtual Surgical Planning: Custom Plates, Dental Implants, Jaw in a Day | Alexandra Kejner |
10:45 AM | Q&A |
Instructional Course 08: Management Update: Nasopharyngeal Carcinoma
Moderator: Ivan El-Sayed
This instructional course will use literature review, anatomical description, and case studies to discuss up to date concepts in the management of nasopharyngeal carcinoma with systemic therapies and surgical management.
At the conclusion of this session, participants will be able to:
- Articulate the role, timing and common strategies for radiotherapy and chemotherapy and immunotherapy in the management of nasopharynx carcinoma.
- Discuss the indications, contraindications and risks of surgical management of nasopharynx cancer.
- Assess the prognostic significance of factors such as histopathology, viral etiology, and tumor staging.
10:00 AM | Introduction | Ivan El-Sayed |
10:03 AM | Radiation and Systemic Therapy for Nasopharynx Cancer | Annie Chan |
10:28 AM | Surgical Considerations for Nasopharynx Carcinoma | Ivan El-Sayed |
10:51 AM | Q&A |
Instructional Course 09: Practical Algorithm for Cutaneous Head and Neck Reconstruction
Moderator: Audrey H. Baker
This will be a case-based discussion on challenging questions regarding the reconstructive options in cutaneous defects of the head and neck. Cases will illustrate the difficult decision regarding margin assessment, timing of reconstruction with adjuvant therapy, and the decision tree to use free tissue transfer or local flap options.
At the conclusion of this session, participants will be able to:
- Incorporate current trends in margin assessment for cutaneous malignancy and integrate this into the reconstructive timeline.
- Allow for different flap reconstructive options based on site-specific and tissue-specific considerations.
- Consider options in timing for adjuvant therapy based on reconstructive and extirpative goals.
10:00 AM | Introduction | Audrey Baker |
10:05 AM | Case 1: Margin Assessment and Reconstructive Timing | Audrey Baker |
10:20 AM | Case 2: Adjuvant Treatment and Reconstructive Timing (Nasal Reconstruction) | Sydney Ch’ng |
10:35 AM | Case 3: Local vs Pedicled vs Free Flap for Cutaneous Reconstruction | Alice Lin |
10:50 AM | Putting It All Together |
10:45 AM – 12:00 PM
Instructional Courses (Concurrent Sessions)
Instructional Course 10: Total Maxillectomy – Resection and Reconstruction Pearls
Moderator: Michael Fritz
This session will provide a practical overview of maxillectomy, with detailed and clinically useful insights from experienced surgeons, whose topics will include a) how to choose the optimal approach; b) specific operative techniques and modifications; c) pitfalls; d) outcomes; and e) the challenges of preserving vs. exenterating the orbit. The first part of the course will focus on Resection and the second part will focus on Reconstruction; both parts will be robustly illustrated with diagrams and clinical photographs, with time for Discussion at the end.
At the conclusion of this session, participants will be able to:
- Choose optimal approaches to total maxillectomy with all its variations and technical modifications.
- Select appropriate reconstructive options for best functional and aesthetic outcomes after total maxillectomy, including revision reconstructions
- Recognize pitfalls and potential complications of total maxillectomy, and formulate plans to avoid and/or rectify them.
11:00 AM | Introduction | Michael Fritz |
11:05 AM | Total Maxillectomy: Approaches, Techniques, Pitfalls, & Outcome | Daniel Nuss |
11:25 AM | Reconstruction of Palatomaxillary Defects: Choices, Techniques, and Results | Michael Fritz |
11:45 AM | Q&A |
Instructional Course 11: Challenges and Considerations for Building a Practice for the Young Head and Neck Surgeon
Moderator: Tammara L. Watts
We will hold an interactive session on topics important to early career head and neck surgeons including transitioning from training to practice, educational strategies when assuming the trainer role, clinical practice building and early career advancement. Common challenges and obstacles will be presented, and personal experiences will be shared by young AHNS members in diverse practice environments.
At the conclusion of this session, participants will be able to:
- Recognize common considerations in finding a first job including geography, academic vs. private practice, clinical opportunities, and research support, common compensation models, physician obligations, and the value of hiring an attorney to review your contract.
- Identify strategies to build your clinical team and consider the effects of regional differences on practice building.
- Describe approaches for early career advancement such as balancing clinical and academic efforts, finding time to develop research ideas, and applying for funding.
11:00 AM | Considerations When Finding Your First Job | Tammara Watts |
11:12 AM | Practice Building | Caitlin McMullen |
11:24 AM | Career Advancement Opportunities | Andres Bur |
11:36 AM | Q&A |
Instructional Course 12: How to Establish a Survivorship Program
Moderator: Barbara Murphy
Head and Neck cancer patients may experience a number of unique and functionally significant late effects from cancer and its therapy. Optimization of survivorship requires a systematic approach to identifying and managing these sequela. In this session we will review critical late effects experienced by head and neck cancer survivors and examine two different models of survivorship care.
At the conclusion of this session, participants will be able to:
- Recognize the late effects issues that face head and neck cancer survivors and the impact on function and quality of life.
- Understand two distinct models of survivorship: the first in an academic setting and the second using a grass roots, patient focused approach and how to develop a private donor funded program.
11:00 AM | The Importance of a Systematic Approach to Head and Neck Cancer Survivorship | Barbara Murphy |
11:10 AM | Models of Care: The University of Pittsburg Experience | Jonas Johnson |
11:30 AM | Developing a Survivorship Program in a Low Resourced and Underfunded Setting | Danielle MacNeil |
11:50 AM | Q&A |
Instructional Course 13: Palliative Surgery in Pursuit of Health
Moderator: Alexander Langerman
Palliative surgery aims to improve the quality of a patient’s remaining life, but the stakes are high: in patients with limited life expectancy, complications can be devastating, and non curative palliative procedures still pose great risk. This case-based discussion will focus on decision making and key considerations for palliative surgical interventions in the head and neck.
At the conclusion of this session, participants will be able to:
- Define and contextualize palliative surgery.
- Understand opportunities for palliative surgery to enhance the care of head and neck patients.
- Develop an approach to decision-making regarding palliative interventions.
11:00 AM | Palliative Surgery | Alexander Langerman |
11:30 AM | Palliative Surgery | Alessandra Colaianni |
Instructional Course 14: Sialendoscopy – Pearls to Proficiency
Moderator: Rohan Walvekar
The instructional course is targeted at surgeons interested in learning more about Sialendoscopy and understanding what needs to be done to start a sialendoscopy practice successfully.
At the conclusion of this session, participants will be able to:
- Create a pathway for initiating a sialendoscopy practice.
- Relate and recognize the breadth of sialendoscopy practice and impact they could have on the care of their patients with related conditions.
- Determine the feasibility of a sialendoscopy practice at their own institution and how to build a successful practice.
11:00 AM | Sialendoscopy – Getting Started | Rohan Walvekar |
11:15 AM | Indications and Interventions | Boyd Gillespie |
11:30 AM | Surgical and Practice Pitfalls | Rahmatulla Rahmati |
11:45 AM | Sialendoscopy Outcomes and Patient Expectations | Jolie Chang |
Instructional Course 15: Update on Non-surgical Treatment of Advanced Cutaneous Cancer
Moderator: Renata Ferraroto
We will review current knowledge and future directions in the non-surgical treatment of advanced non-melanoma cutaneous cancer, including cutaneous squamous cell carcinoma, basal cell carcinoma and merkel cell carcinoma.
At the conclusion of this session, participants will be able to:
- Demonstrate an understanding of standard of care non-surgical treatment for non-melanoma skin cancers, with a focus on immunotherapy.
- Understand biomarkers being developed for disease monitoring and prediction of treatment benefit.
- Describe therapeutic advances and future directions in the management of non-melanoma skin cancers.
11:00 AM | Systemic Therapy for Advanced, Non-Resectable Non-Melanoma Skin Cancers: Standard of Care Available Options | Renatta Ferrarotto |
11:25 AM | Novel Intratumoral and Systemic Therapies and Biomarkers of Disease Monitoring in Non-Melanoma Skin Cancer | Cecilia Schmalbach |
11:50 AM | Q&A |
Instructional Course 16: The Scapula Flap
Moderator: Kevin Fung
This session will feature case-based presentations and practical tips and pearls for approaches to mid face, oromandibular, and other HN defects utilizing the subscapular system of flaps.
At the conclusion of this session, participants will be able to:
- Understand the surgical anatomy and technical aspects of the subscapular system of flaps.
- Understand common pitfalls and develop an approach to avoid them.
- Develop a practical approach to reconstruction of the midface and mandible.
11:00 AM | Introduction | Kevin Fung |
11:05 AM | Oromandibular Defect Reconstruction | Judith Skoner |
11:20 AM | Midface Defect Reconstruction | Antoine Eskander |
11:35 AM | Pearls/Tips/Lessons Learned from Screwing Up | Kevin Fung |
11:50 AM | Q&A |
Instructional Course 17: Carotid Management in Skull Base Surgery
Moderator: Ricardo Carrau
Considering all risk factors and alternatives for treatment is critical to prevent devastating complications. The course will provide guidelines toward the planning and execution of a protocol to stabilize intraoperative hemorrhage, including resuscitation, heparinization and focal packing (preferably with crushed muscle), followed by angiography and endovascular treatment. Clinical and radiological monitoring to prevent early and late complications will be discussed.
At the conclusion of this session, participants will be able to:
- Evaluate various options for the treatment of skull base tumors involving the ICA.
- Identify risk factors for an ICA injury.
- Plan the perioperative management of an injured ICA.
11:00 AM | Introduction | Ricardo Carrau |
11:05 AM | Management of Skull Base Tumors Involving the ICA | C. Arturo Solares |
11:25 AM | Perioperative Management of the Injured ICA | Nyall London |
11:45 AM | Q&A |
Instructional Course 18: Update in Facial Nerve Reconstruction
Moderator: Philip Daniel Knott
We will use a lecture/case based format for the 3 speakers to introduce the major salient topics for oncologic reanimation; namely treatment of the radical parotidectomy and/or lateral skull base surgery, treatment of post-treatment synkinesis, and salvage of the failed reanimation. The second half of the session will feature a case-based discussion format to review management strategies and treatment decision-making.
At the conclusion of this session, participants will be able to:
- Identify treatment algorithms that will yield the best post-treatment facial nerve reanimation outcomes.
- Manage both immediate and long term complications associated with facial nerve treatment challenges.
- Understand the rationale underlying selective denervation and selective myectomy with the optimization of outcomes encompassing both muscle tone and excursion.
11:00 AM | Immediate Management of Facial Nerve Sacrifice | Irene Kim |
11:13 AM | Long-term Management of Facial Nerve Dysfunction | Leslie Kim |
11:26 AM | Salvage of the Failed Reanimation | Daniel Knott |
11:39 AM | Case Presentation and Q&A |
12:00 PM – 1:30 PM
Lunch (on own)
1:30 PM – 2:30 PM
Instructional Courses (Concurrent Sessions)
Instructional Course 19: Head and Neck Lymphedema and Fibrosis
Moderator: Heather Starmer
We will identify current therapy options and investigate related research for HNL and fibrosis.
At the conclusion of this session, participants will be able to:
- Distinguish between head and neck lymphedema and fibrosis.
- Demonstrate understanding of the relationship of lymphedema and fibrosis to functional outcomes.
- Identify appropriate treatment recommendations for patients with lymphedema and fibrosis.
1:30 PM | Introduction to Lymphedema and Fibrosis | Heather Starmer |
1:37 PM | Differentiating Lymphedema and Fibrosis in Head and Neck Cancer Patients | Barbara Murphy |
1:52 PM | The Functional Impact of Lymphoedema and Fibrosis on Swallowing, Speech and Voice | Claire Jeans |
2:07 PM | Treatment of Head and Neck Lymphedema and Fibrosis | Holly McMillan |
2:22 PM | Q&A |
Instructional Course 20: Radiation Oncology Update: Opportunities for De-escalation
Moderator: Beth Beadle
We will review current data on the use of radiation therapy for head/neck cancers in the definitive and post-operative setting, with a focus on the clinical outcomes and toxicity from trials evaluating de-escalation. We will explore appropriate diseases in which to consider de-escalation and focus on methods of de-escalation, including use of surgery, altered chemotherapy regimens, and altered radiation regimens (dose, target, and technique).
At the conclusion of this session, participants will be able to:
- Identify appropriate head/neck cancers to consider de-escalation and potential risks/benefits.
- Evaluate the clinical trials testing de-escalation and interpret the results.
- Compare outcomes and toxicity from standard and de-escalated treatment paradigms.
1:30 PM | Standard of Care for Head/Neck Cancers: Benefits and Risks of “Full-dose” Treatment | Beth Beadle |
1:50 PM | De-escalation for Head/Neck cancers: Benefits and Risks of “De-escalated” Treatments | Richard Wong |
2:10 PM | Q&A |
Instructional Course 21: What is the Current Role in Neoadjuvant Therapy
Moderator: Eleni Rettig
We will present updates in the use of neoadjuvant immunotherapy and chemotherapy for both mucosal and cutaneous squamous cell carcinomas of the head and neck. Relevant clinical trials and sample cases will be discussed.
At the conclusion of this session, participants will be able to:
- Discuss recent clinical trials examining neoadjuvant immunotherapy for head and neck cutaneous and mucosal disease.
- Integrate findings from major clinical trials of neoadjuvant chemotherapy into management of head and neck mucosal disease.
- Recognize implications of neoadjuvant therapy for surgical planning.
1:30 PM | Introduction | Eleni Rettig |
1:35 PM | Neoadjuvant Chemotherapy for Head and Neck Mucosal Disease and Larynx Preservation | Robert Haddad |
1:55 PM | Neoadjuvant Immunotherapy for Mucosal and Cutaneous Head and Neck Disease | Ari Rosenberg |
2:15 PM | Case Discussion and Q&A |
Instructional Course 22: Intraoperative Nerve Monitoring – State of the Art
Moderator: Gregory Randolph
This instructional course will review basics pearls of application and applications of nerve monitoring for continuous monitoring and Superior laryngeal nerve monitoring. We will conclude with a case-based panel.
At the conclusion of this session, participants will be able to:
- Troubleshoot neural monitoring systems.
- Apply neural monitoring to the superior laryngeal nerve.
- Discern the potential advantage of continuous monitoring.
1:30 PM | Introduction | Gregory Randolph |
1:32 PM | IONM – Guidelines, Troubleshooting and Pearls | Amanda Silver |
1:47 PM | IONM – What Outcomes Do We Affect ? Continuous vs Intermittent | Catherine Sinclair |
2:02 PM | SLN | |
2:07 PM | IONM Panel Cases and Q&A |
Instructional Course 23: The ‘How To’ of Sentinel Lymph Node Mapping for Oral Cavity Cancers
Moderator: Francisco Civantos
We will use a combination of case presentations and lectures to discuss patient selection, injection technique, surgical technique, pathological technique, and subsequent adjuvant management, of patients undergoing sentinel node biopsy for oral cavity cancer. Potential future innovations in techniques and management, including implications of the ongoing randomized trial comparing selective neck dissection and sentinel node biopsy, will be discussed.
At the conclusion of this session, participants will be able to:
- Properly select patients with early oral cancer for sentinel node biopsy versus neck dissection or observation.
- Begin developing their surgical technique for sentinel node biopsy, in the context of gamma probe guided neck dissections, (or refine their surgical technique for sentinel node biopsy, if already experienced).
- Discuss and understand the newest technical innovations in pathology and surgical technique for the selection of patients for sentinel node, for removal of sentinel nodes, and for identification of small metastases. Implications of these innovations, and potential innovations of an ongoing randomized trial will be understood.
1:30 PM | Patient Selection for Sentinel Node Biopsy: Current Approach and Possible Future Innovations | Karen Choi |
1:45 PM | Surgical Technique of Sentinel Node Biopsy for Oral cancer: Standards and Controversies | Sandeep Samant |
2:00 PM | New Innovations and Developments in Minimally Invasive Neck Management | Francisco Civantos |
2:15 PM | Q&A |
Instructional Course 24: Advances in the Management of Head and Neck Melanoma
Moderator: Alex Mlynarek
This session will discuss recent advances in the non-surgical management of high-risk and metastatic melanoma. This will include a discussion of new targeted therapy, immunotherapy, and oncolytic virus strategies as well as the current approach to treatment planning for patients with high-risk melanoma. Additional description of advances in the adjuvant and neoadjuvant setting will be discussed, including the role for imaging and predictive biomarker analysis in patient monitoring and treatment decision making.
At the conclusion of this session, participants will be able to:
- Distinguish the different mechanisms and indications for recently approved medical therapy for patients with head and neck melanoma.
- Develop a rational diagnostic and treatment strategy for patients with high-risk and metastatic head and neck melanoma.
- Describe the role of neoadjuvant and adjuvant treatment for patients presenting with locally advanced head and neck melanomas.
1:30 PM | Role, Indications and Technique of SLNB in 2023 | Alex Mlynarek |
1:50 PM | Adjuvant and Neoadjuvant Systemic Treatments | Kerwin Shannon |
2:10 PM | Current Trials, Additions to Immunotherapy/Targeted Therapies for Advanced/Metastatic Disease | Howard Kaufman |
Instructional Course 25: Local and Regional Flaps in Oral Cavity Reconstruction
Moderator: Stephen Bayles
This session will explore local and regional flap options for oral cavity defects when microvascular options are unavailable or potentially inappropriate. It will outline selection criteria, advantages and disadvantages of an array of local and regional flap options to achieve acceptable reconstructive goals in appropriately chosen patients.
At the conclusion of this session, participants will be able to:
- Identify those patients best suited for local /regional reconstruction options for oral cavity defects over advanced techniques.
- Prioritize outcomes of reconstruction based on preoperative assessment of comorbidities, premorbid functional status, and donor site availability.
- Integrate, design, and execute on a wide variety of locoregional flap techniques to achieve successful reconstructive goals in some of the most challenged patients.
1:30 PM | Local and Regional Flaps in Oral Cavity Reconstruction | Stephen Bayles |
2:00 PM | Local and Regional Flaps in Oral Cavity Reconstruction | Angela Haskin |
Instructional Course 26: State of the Art in Paraganglioma Management
Moderator: Matthew Old
We will use a case-based hybrid video format to discuss the etiology, diagnosis and management of head and neck paragangliomas and similar tumors and address the controversies and new treatment paradigms.
At the conclusion of this session, participants will be able to:
- Recognize the different etiologies and presentations of head and neck paragangliomas.
- Diagnose and recognize the spectrum of paragangliomas and similar tumors throughout the head and neck.
- Formulate treatment plans for head and neck paragangliomas.
1:30 PM | State of the Art Management of Head and Neck Paragangliomas | Matthew Old |
2:00 PM | State of the Art Management of Head and Neck Paragangliomas | James Netterville |
Instructional Course 27: Immunotherapy 101 – How it Works
Moderator: Nicole Schmitt
We will introduce the basic concepts of tumor immunology and strategies for immunotherapy. Next, we will review approved indications for immunotherapy in head and neck cancer and briefly highlight some ongoing research.
At the conclusion of this session, participants will be able to:
- Understand the basics of tumor immunology and immunotherapy.
- Articulate the approved indications for immunotherapy in head and neck cancer.
- Describe the rationale and endpoints of some ongoing clinical trials for immunotherapy in head and neck cancer.
1:30 PM | Basic Tumor Immunology | Nicole Schmitt |
1:45 PM | Approved Indications and Ongoing Trials- Recurrent/Metastatic Disease | Michael Gibson |
2:00 PM | Clinical Trials for Previously Untreated Disease |
2:30 PM – 3:30 PM
Instructional Courses (Concurrent Sessions)
Instructional Course 28: SLP and Laryngology Care to Optimize Function after Transoral Robotic Oropharyngeal Surgery
Moderator: Katherine Hutcheson
Interdisciplinary protocols and procedures to improve function after TORS for oropharyngeal cancer will be discussed. The panel will review published protocols, supportive care models integrated into recent trials, and use a case based approach to highlight opportunities to personalize care and improve functional outcomes.
At the conclusion of this session, participants will be able to:
- Describe published perioperative models of SLP care for swallowing support during hospitalization.
- Describe rationale for use of instrumental swallowing evaluation after TORS.
- Describe laryngological procedures to improve function after TORS including indications and expected outcomes.
2:30 PM | Surgical Selection and Technique Underlying Swallow Preservation After TORS | Michael Moore |
2:42 PM | TORS SLP Care Pathway: Early Intervention Following TORS | Lauren Ottenstein |
2:54 PM | Supportive Care and SLP Care After TORS in ORATOR/ORATOR2: What We Did and What We Learned | Julie Theurer |
3:06 PM | Dysphagia After Oropharyngeal Cancer: What is the Surgeon’s Role? | Karuna Dewan |
3:18 PM | Q&A |
Instructional Course 29: Strategies for Successful Parathyroid Surgery
Moderator: Russell Smith
We will use multiple small presentations on specific aspects of preoperative assessment and intraoperative decision making to delineate strategies to ensure optimal outcomes with parathyroid surgery. We will conclude with a short discussion of a representative case to emphasize the concepts presented in the instructional course.
At the conclusion of this session, participants will be able to:
- Appropriately select patients who will likely benefit from parathyroid surgery.
- Formulate a plan for preoperative imaging for parathyroid pathology localization.
- Formulate an operative plan based upon patient assessment including preoperative imaging.
2:30 PM | Introduction and Preoperative Assessment | Erin Buczek |
2:50 PM | Intraoperative Decision Making | Russell Smith |
3:10 PM | Q&A |
Instructional Course 30: Accelerate Your Clinical Research Program
Moderator: Joseph Curry
We will discuss key aspects of developing a translational and Basic science cancer program that fuels a strong clinical research program, as well as developing a clinical cancer research program around scientific program strengths.
At the conclusion of this session, participants will be able to:
- Prioritize the key steps necessary for development of a successful cancer research program.
- Organize a successful plan to develop a cancer research program.
- Recognize the common pitfalls that sideline, stall and disrupt a cancer research program.
2:30 PM | Developing a Translational and Basic Science Cancer Program that Fuels a Strong Clinical Research Program | Sana Karam |
3:00 PM | Developing a Clinical Cancer Research Program Around Scientific Program Strengths | Joseph Curry |
Instructional Course 31: Update on Quality Metrics and Initiatives in Head and Neck Cancer
Moderator: Evan Graboyes
This session will describe the current landscape of quality metrics and quality improvement initiatives in head and neck oncology, with a focus on the recently approved Commission on Cancer quality metric for timely initiation of adjuvant radiation therapy following surgery for head and neck cancer. In addition, this session will identify strategies and challenges to establishing data collection infrastructure at the institutional and national levels, and highlight ongoing quality initiatives to decrease disparities in head and neck cancer access and outcomes.
At the conclusion of this session, participants will be able to:
- Recognize a variety of pre-treatment, treatment, and post-treatment quality metrics in head and neck oncology and choose metrics for reporting at their institution.
- Evaluate the rationale for the Commission on Cancer selecting the initiation of postoperative radiation therapy within 6 weeks of surgery as a quality metric in head and neck oncology and describe potential limitations of this quality metric.
- Convey how ongoing quality improvement initiatives can decrease disparities in access and outcomes among patients with head and neck cancer.
2:30 PM | Update on Quality Metrics and Initiatives in Head and Neck Cancer: Part 1 | Evan Graboyes |
3:00 PM | Update on Quality Metrics and Initiatives in Head and Neck Cancer: Part 2 | Mark Prince |
Instructional Course 32: Management of Laryngeal Dysplasia and Early Stage Cancer
Moderator: Dinesh Chhetri
We will use case presentations to discuss evaluation and management of laryngeal dysplasia and early stage laryngeal cancer. Principles of laser surgery, surgical techniques, and patient follow-up considerations will be highlighted.
At the conclusion of this session, participants will be able to:
- Differentiate the challenges in managing laryngeal dysplasia versus early laryngeal cancer.
- Develop an endoscopic treatment plan for laryngeal dysplasia and cancer.
- Generate a surveillance plan for laryngeal dysplasia and cancer.
2:30 PM | Laryngeal Dysplasia and Early Carcinoma: Assessment | Dinesh Chhetri |
2:45 PM | Laryngeal Dysplasia and Early Carcinoma: Treatment | Joshua Schindler |
3:00 PM | Laryngeal Dysplasia and Early Carcinoma: Outcomes and Surveillance | Dinesh Chhetri & Joshua Schindler |
3:15 PM | Q&A |
Instructional Course 33: Surgical Salvage for High-Risk Cutaneous Cancer Patients
Moderator: Steven Wang
We will provide a current update on surgical salvage treatment for high-risk cutaneous cancers, including conventional treatment failures, solid organ transplant recipients, and locally advanced recurrences with perineural/skull base involvement. The role of immunotherapy and other systemic therapies as part of salvage treatment strategies in this challenging patient population will also be discussed.
At the conclusion of this session, participants will be able to:
- Articulate the role of immunotherapy for those cutaneous cancer patients who fail conventional treatment.
- Manage solid organ transplant patients needing surgical salvage.
- Discuss role of surgery for cutaneous cancers with skull base and/or perineural recurrence.
2:30 PM | Surgical Salvage for Cutaneous Cancers in the Era of Immunotherapy | Steven Wang |
2:55 PM | Surgical Salvage for Locally Advanced Cutaneous Cancers in Solid Organ Transplant Recipients | Marcus Monroe |
3:20 PM | Q&A |
Instructional Course 34: Genetics of Head and Neck Cancer – What You Need to Know
Moderator: Luc Morris
Using case vignettes, we will discuss how to think about tumor genomic profiling for your patients with head and neck cancer, thyroid nodules, and how these tests can help with the management of advanced skin cancers, thyroid nodules, and oral cancers in young patients.
At the conclusion of this session, participants will be able to:
- Use tumor genomic profiling assays to take better care of patients.
- Recognize clinically actionable findings in tumor genomic data.
- Understand current research on leveraging tumor genomic biomarkers to develop better therapies.
2:30 PM | Introduction to Clinical Genomics in HNC | Luc Morris |
2:38 PM | Young Patients with Oral Tongue Cancer: Genetic Insights | Theresa Guo |
2:48 PM | Genomic Biomarkers to Guide Immunotherapy | Luc Morris |
2:54 PM | Genetics of Advanced Skin SCC | Theresa Guo |
3:04 PM | How to Interpret Thyroid Molecular and Genetic Assays | Luc Morris |
3:12 PM | Q&A |
Instructional Course 35: State of the Art in Management of Advanced Skull Base Malignancies
Moderator: Shirley Su
This session will use short presentations and case examples to illustrate diagnostic and imaging “pearls” along with multi-modality management strategies for advanced skull base malignancies involving the orbit, facial skeleton and anterior cranial fossa. The role for endoscopic and open surgical approaches as well as neoadjuvant and adjuvant therapies will be presented.
At the conclusion of this session, participants will be able to:
- Recognize the role, timing and combinations of surgery, radiotherapy, chemotherapy and immunotherapy in the management of advanced anterior skull base malignancies.
- Identify the indications and contraindications for: i) endoscopic vs. open surgery and ii) orbital preservation vs. exenteration.
- Predict overall and disease specific survival based on a number of factors including histopathology, disease extent, margin status and adjuvant therapies.
2:30 PM | Introduction | Shirley Su |
2:35 PM | Management Principles | Ian Witterick |
2:45 PM | Surgical Approaches | Ivan El-Sayed |
2:55 PM | Adjuvant/Neoadjuvant Therapies | Shirley Su |
3:05 PM | Illustrative Case Examples |
Instructional Course 36: Immunotherapy 201 – What to Expect
Moderator: Michael Gibson
This session will focus on the following topics: Review of current IO status in HNSCC, the HNSCC immune landscape as we know it, ongoing trials that could shape the near-term, unmet needs, biomarker development, and promising agents and modalities.
At the conclusion of this session, participants will be able to:
- Identify major determinants of the tumor microenvironment in HNSCC.
- Appraise the next generation of immunotherapy agents in HNSCC.
- Compare utility of predictive biomarkers for immunotherapy in HNSCC.
2:30 PM | Current Status and Near Term Challenges in HNSCC Immunotherapy | Michael Gibson |
2:52 PM | Promising Agents and Modalities in HNSCC Immunotherapy | Ezra Cohen |
3:14 PM | Q&A |
3:30 PM – 4:00 PM
PM Break
4:00 PM – 5:00 PM
Instructional Courses (Concurrent Sessions)
Instructional Course 37: Optimizing Post-Laryngectomy Function
Moderator: Julia Maclean
Patients deserve optimal care to avoid complications and give them the highest chance to optimize quality of life after this life-changing surgery. In this session, participants will be educated on counseling, surgical techniques and rehabilitation strategies to optimize post-laryngectomy function.
At the conclusion of this session, participants will be able to:
- Recognize how several surgical techniques can influence post-surgery function.
- Use practical methods to manage the common problems seen with voicing and swallowing after laryngectomy.
- Understand the importance of a dedicated rehabilitation team after laryngectomy.
4:00 PM | Optimizing Rehabilitation and Avoiding Complications in Total Laryngectomy Surgery | Ryan Goepfert |
4:10 PM | Surgical Considerations to Optimize Breathing, Voice and Swallowing | Michiel Vandenbrekel |
4:20 PM | Dysphagia Following Total Laryngectomy | Tamar Kotz |
4:30 PM | Case Discussion |
Instructional Course 38: Nuances of Pediatric Thyroid Cancer
Moderator: Ken Kazahaya
We will present some of the differences and considerations in the management of pediatric thyroid cancer. We will present some preoperative, intraoperative, and post-operative management options particular to the pediatric population.
At the conclusion of this session, participants will be able to:
- Develop a better understanding of decisions regarding ultrasound-guided fine-needle aspiration in the pediatric population.
- Identify differences in intraoperative management between pediatric and adult patients.
- Understand some of the pediatric post-thyroidectomy treatment paradigms.
4:00 PM | Preoperative Considerations in Management of Pediatric Thyroid Cancer | Ryan Belcher |
4:15 PM | Intraoperative Considerations in Management of Pediatric Thyroid Cancer | Gillian Diercks |
4:30 PM | Post-Thyroidectomy Considerations in Pediatric Thyroid Cancer Management | Ken Kazahaya |
4:45 PM | Q&A |
Instructional Course 39: Accelerate Your Clinical Research II: Running Clinical Trials
Moderator: Stephen Lai
Evaluation of medical interventions and surgical procedures that will alter the standard of care require the highest level of clinical evidence. We will discuss our experience in developing and activating clinical trials at the institutional and multi-institutional, cooperative group levels.
At the conclusion of this session, participants will be able to:
- Articulate the challenges and potential strategies related to patient accrual for clinical trials.
- Describe the challenges and potential solutions for funding and institutional support of clinical trials.
- Articulate the steps required to move a clinical trial from initial concept to formal activation.
4:00 PM | Challenges and Pitfalls in Clinical Trials | Derrick Lin |
4:25 PM | Developing Cooperative Group Trials: Concept to Activation | Stephen Lai |
4:50 PM | Q&A |
Instructional Course 40: Tracheal Resection and Reconstruction
Moderator: Eric Genden
In this session, we will discuss the approach to management of patients with tracheal stenosis. We will discuss standard and advanced techniques in diagnosis, management, and complications.
At the conclusion of this session, participants will be able to:
- Articulate the diagnostic and therapeutic approach to a patient with tracheal stenosis.
- Create a treatment algorithm for management of complex airway disease.
- Discuss and review management of complication of airway reconstruction.
4:00 PM | The Standard Approach and Management of Tracheal Stenosis | Alexander Gelbard |
4:30 PM | The Management of Complex Tracheal Airway Stenosis | Eric Genden |
Instructional Course 41: Patient Selection for Salvage Surgery
Moderator: Gina Jefferson
We will use evidence to provide patient considerations for salvage head and neck surgery including patients at risk for recurrent disease, medical and surgical factors that require consideration for salvage surgery and surgical interventions. We will approach the topic by subsite and address potential complications as well as prognosis.
At the conclusion of this session, participants will be able to:
- Describe HNC patients at risk for persistent/recurrent disease that surgeons would consider for surgical salvage intervention.
- Articulate by head and neck subsite potential surgical management strategies for persistent/recurrent disease.
- Discuss prognosis and anticipated functional outcomes for patients undergoing salvage surgery of the head and neck by subsite.
4:00 PM | Introduction: Who, Risk Factors | Gina Jefferson |
4:10 PM | Salvage Surgery Considerations by Subsite | Benjamin Judson |
4:25 PM | Microvascular Reconstruction Considerations | Gina Jefferson |
4:40 PM | Prognosis, Complications and Functional Outcomes | Benjamin Judson |
4:50 PM | Case Presentation | |
4:55 PM | Q&A |
Instructional Course 42: NCI/NIDCR Sponsored Course – Early Detection
Moderator: Chad Brenner
In this session we will have an open discussion to explore the opportunities to incorporate Circulating tumor DNA (ctDNA) testing into the management of HPV+ HNSCC, in order to discuss the current limitations of testing that providers should know. Providers need to understand the potential benefits and limitations of ctDNA testing, such as the need for confirmation with imaging or tissue-based testing, the potential for false-positive or false-negative results, and the impact of the tumor burden on ctDNA levels.
At the conclusion of this session, participants will be able to:
- Distinguish between CLIA certified ctDNA tests available for patients as lab developed tests.
- Convey the limitations of current ctDNA testing strategies.
- Assess the value of ctDNA testing in different clinical scenarios.
4:00 PM | Circulating Tumor DNA Testing in HPV Related Oropharynx Cancer | Chad Brenner |
4:15 PM | Q&A | |
4:20 PM | Implementation Challenges with CtDNA Testing for Early Detection | Catherine Haring |
4:35 PM | Q&A | |
4:40 PM | EGFR-based PET Imaging for Early Detection of Cancer | Eben Rosenthal |
4:55 PM | Q&A | |
5:00 PM | NIDCR-NCI’s Collaborations on Head and Neck Cancer Research | Chen Zhong & Wendy Wang |
5:15 PM | Q&A | |
5:20 PM | Promoting Head and Neck Cancer Research in Early Detection, Prevention, and Biomarker Identification? |
Instructional Course 43: Unusual But Very Useful Research Techniques – The Head and Neck Cancer Inter Group (HNCIG) Experience
Moderator: Hisham Mehanna
This session will discuss and explore research techniques that may not be widely used but can be very potent and useful when undertaking research, especially in large or international research collaborations. We will discuss the Delphi process for gaining consensus, the harmonization of trial outcome measures and using AI to collect large amounts of data. We will then have a discussion panel on challenges of building international collaborations and running multinational studies and how to address them. This session promises to be interesting, informative and instructional, and is of use to all researchers from students all the way to professors.
At the conclusion of this session, participants will be able to:
- Articulate what each of these novel research methodologies means and circumstances where they would be useful.
- Illustrate examples of when to use each method.
- Choose the method most appropriate for the research question when undertaking research in the future.
4:00 PM | The Process of Gaining Consensus for Low-evidence Conditions | Christina Henson |
4:10 PM | Harmonization of HNC Trial Outcome Measures Across the World | Sue Yom |
4:20 PM | AI-driven Data Collection – The TACTIC Multinational Study | Sujith Baliga |
4:30 PM | Discussion Panel: The Challenges of Building International Collaborations and Running Multinational Studies | Lachlan McDowell, Sujith Baliga, Luiz Kowalski, Sue Yom, Christina Henson |
Please join us at the pre-meeting expo from 4:00 PM – 6:00 PM in room 522ABC for a hands-on learning experience supported in part by Cook Medical.
8:00 AM – 9:30 AM
Opening Ceremony
9:30 AM – 10:15 AM
John J. Conley Lecture
Introduction: Brian Burkey
10:15 AM – 10:45 AM
Break in Exhibit Hall
Room 220BCDE
10:45 AM – 12:15 PM
Controversies in Osseus Reconstruction
Moderator: Jonathan Clark
In this session we will discuss a variety of controversial topics in osseous free flap reconstruction of the maxilla and mandible. This will range from the management of hardware-related and other complications, the use of scapular, iliac crest and other non-fibula flaps, when virtual surgical planning is required, and how patient reported outcome measures can be integrated into routine clinical practice and research. The session will finish with case-based discussion.
At the conclusion of this session, participants will be able to:
- Decide when bone flaps other than the fibula should be considered and understand when virtual surgical planning is a necessity or just a convenience.
- Prevent and better manage complications following osseous free flap reconstruction.
- Integrate patient reported outcomes into routine clinical care following jaw reconstruction.
10:45 AM | Virtual Surgical Planning – Necessity or Convenience | Neal Futran |
11:00 AM | Management of Plate Infections, Plate Failure, Postoperative Fistula and Other Complications Following Jaw Reconstruction | Liana Puscas |
11:15 AM | Non-fibula Flaps in Jaw Reconstruction | Kyle Mannion |
11:30 AM | Integrating Objective and Patient Reported Outcomes into Jaw Reconstruction | Julia Maclean |
11:45 AM | Case Presentations and Discussion |
10:45 AM – 12:15 PM
New Concepts in Head and Neck Cancer Epidemiology
Moderator: Carole Fakhry
This session will review the epidemiology of human papillomavirus in head and neck cancer. Discussion of the potential role of liquid biopsy will be discussed in both the prevention and surveillance settings.
At the conclusion of this session, participants will be able to:
- Identify the role of HPV in non-oropharyngeal cancer.
- Articulate the state of primary and secondary prevention for HPV-related oropharynx cancer.
- Discuss the potential benefits and limitations of knowledge regarding liquid biopsy in surveillance for HPV-related oropharynx cancer.
10:45 AM | Epidemiologic Nuances in HPV and Head and Neck Cancer (Oropharynx and Non-oropharynx) | Eleni Rettig |
11:05 AM | Primary and Secondary Prevention | Gypsyamber D’Souza |
11:25 AM | Liquid Biopsy in the Surveillance Setting for HPV-related Head and Neck Cancers Setting | David Neskey |
11:45 AM | Panel Case Discussion |
10:45 AM – 12:15 PM
Transoral Minimally Invasive Surgery: Controversies and Cases
Moderator: Chris Holsinger
Transoral Minimally Invasive Surgery using traditional approaches, the robot or laser plays an important role in managing oral and oropharyngeal cancers. From the role of TLM to management of retropharyngeal adenopathy and free-flap reconstruction, this panel will address time-honored and cutting-edge technique and research including a discussion of international ongoing clinical trials research.
At the conclusion of this session, participants will be able to:
- Articulate the role of technology (traditional electrocautery, robotics and/or laser) in transoral minimally invasive head and neck surgery.
- Describe ongoing prospective clinical trials in transoral minimally invasive head and neck surgery.
- Define the role of free-flap reconstruction after transoral robotic surgery for oropharyngeal cancers.
10:45 AM | Prospective Clinical Trials in Transoral H&N Surgery: From Best-of to Pathos | Christian Simon |
11:00 AM | To Flap or Not to Flap: The Role of Salvage TORS After Previous XRT | Elizabeth Nicolli |
11:15 AM | Don’t Forget the Laser? The Role of TLM in 2023 | Bruce Haughey |
11:30 AM | Transoral Robotic Approach for Retropharyngeal Lymph Node (RPLN) Metastasis: Controversies and Technique | Eun Chang Choi |
11:45 AM | It’s a Trap! Refining Traditional Transoral Approaches for Oral Cavity Cancer | Ashok Shenoy |
12:00 PM | Q&A |
10:45 AM – 12:15 PM
Proffered Papers Sessions
1 – Cancer Biology (1)
2 – Endocrine (1)
3 – Radiation (1)
4 – Reconstruction (1)
5 – Oropharnyx (1)
Industry Symposia (Concurrent Sessions)
12:15 PM – 1:45 PM
Lunch provided
Room 518ABC
Presented by Regeneron
Speaker: Badri G. Modi, MD
Title: Co-managing Patients with Advanced Basal Cell Carcinoma (aBCC) and Advanced Cutaneous Squamous Cell Carcinoma (aCSCC) in the Immunotherapy Era
Room 519AB
Presented by Naveris
Presenters: Chris Holsinger, MD, FACS; Glenn Hanna, MD; Bhisham Chera, MD
Topic: From Insight to Action: A Case-based Discussion on the Utility of NavDx®: A Unique Blood-Based DNA Test for HPV-Driven Oropharyngeal Cancer
1:45 PM – 3:15 PM
Laryngeal Preservation
Moderator: Cherie-Ann Nathan
In 2017, an ASCO Expert Panel reviewed evidence that supports treatment strategies intended to preserve laryngeal function and published comprehensive guidelines. Hence we will review and address the 2017 guidelines and literature that supports those guidelines and additional data that has emerged over the past 5 years including immunotherapy trials. We will have talks addressing multimodality treatment and rehabilitation for the first half of the session followed by case presentations.
At the conclusion of this session, participants will be able to:
- Determine what are the larynx-preservation treatment options for advanced-stage (T3, T4) and neck nodes that do not compromise survival, and what are the considerations in selecting among them.
- Identify role of neoadjuvant chemotherapy and immunotherapy in larynx cancer.
- Determine the best measures to evaluate airway, voice, and swallowing function to determine the best function-preservation treatment or to recommend laryngectomy and for the pre- and post-treatment assessment of function.
1:45 PM | Introduction | Cherie-Ann Nathan |
1:47 PM | When are Radiation-Based Approaches for Larynx Preservation Appropriate? Weighing Cancer Control and Function with Modern Techniques | Beth Beadle |
1:57 PM | Neoadjuvant Approaches to Larynx Preservation | Robert Haddad |
2:07 PM | Is There a Role for Conservation Laryngeal Surgery in 2023? | Michael Hinni |
2:17 PM | Open Partial Horizontal Laryngectomy Type II for the Management of T1b-2 Glottic SCC | Fernando Dias |
2:27 PM | Speech and Swallow Rehabilitation after Laryngeal Cancer | Karuna Dewan |
2:37 PM | Case Discussions |
1:45 PM – 3:15 PM
Scary Cases – Managing Head and Neck Complications
Moderator: Mark Wax
We will use a case management format to discuss unusual and difficult to manage circumstances following head and neck ablative and reconstructive surgery. Each presenter will present a case that was difficult to manage and perhaps had a suboptimal outcome. Panelists will then be asked for suggestions as to how to optimize management.
At the conclusion of this session, participants will be able to:
- Demonstrate understanding of how suboptimal outcomes can develop.
- Understand the role of examining the outcome to formulate a learning paradigm for the future.
- Integrate multiple approaches to solving difficult situations.
1:45 PM | Reconstructive Scalp Complications | Mark Wax |
1:57 PM | Reconstructive Laryngopharyngectomy Complications | Nicole Fowler |
2:09 PM | Intractable Bleeding (Thyroidectomy/Neck Dissection) | Raymond Chai |
2:21 PM | Reconstruction in the Elderly | Neerav Goyal |
2:33 PM | Reconstructive Mandible Complications | Tamer Ghanem |
2:45 PM | Long-term Impact of Radiotherapy | Richard Hayden |
2:57 PM | The Hostile Neck! | Audrey Baker |
3:09 PM | Q&A |
1:45 PM – 3:15 PM
Tumor Board Topics: Skin Cancer
Moderator: Kevin Emerick
This session will use a cased based tumor board format to highlight the key principles in the management of advanced skin cancers. We will focus on the growing role of systemic therapies and evolving roles for surgery and radiation.
At the conclusion of this session, participants will be able to:
- Describe the current common practice for systemic therapy in the neoadjuvant and adjuvant setting for melanoma.
- Understand the current indications for systemic therapy in locally advanced and metastatic non melanoma skin cancers.
- Be able define the role for surgical management of skin cancers as well the role for radiation in the primary and adjuvant setting.
Panelists: Laura Ferris, Felix Nguyen, Kirsten Stenson, Michael Gibson, Trinicia Cannon
1:45 PM | Introduction | Kevin Emerick |
1:50 PM | Prevention and Initial Treatment for Primary Lesions and Regionally Metastatic Lymph Nodes | |
2:20 PM | Adjuvant Treatment for Advanced and Regionally Metastatic Skin Cancers | |
2:50 PM | Neoadjuvant Treatment for Advanced Skin Cancers |
1:45 PM – 3:15 PM
Proffered Papers Sessions
6 – Cancer Biology (2)
7 – Oral Cavity (1)
8 – Skin (1) & Hot Topics (1)
9 – Reconstruction (1)
10 – Salivary (1)
3:15 PM – 3:45 PM
Break in Exhibit Hall
Room 220BCDE
3:45 PM – 5:15 PM
Controversies in N0 neck
Moderator: Yelizaveta Shnayder
This session will present information on controversial issues in management of the cervical lymph nodes in N0 neck including oral cavity cancers, HPV positive and negative oropharynx cancers and thyroid cancers. This is a multidisciplinary panel which includes head and neck surgeons, radiation oncologists and craniomaxillofacial surgeons. This panel will be interactive and include question and answer session and case based discussions.
At the conclusion of this session, participants will be able to:
- Recognize controversial issues in management of N0 neck in oral cavity cancers.
- Recommend radiation approaches in treating cervical lymph nodes in head and neck cancers.
- Discuss treating N0 neck in well differentiated thyroid cancer.
3:45 PM | Introduction and Background | Yelizaveta Shnayder |
3:50 PM | Management of N0 Neck in Oral Cavity | Steffen Koerdt |
4:05 PM | N0 Neck in Oropharynx Cancer: HPV Positive vs Negative | Amit Agrawal |
4:20 PM | N0 Neck in Well Diff Thyroid Ca | Claudio Cernea |
4:35 PM | Radiation Approaches to Treating N0 Neck in Head and Neck and/or Other Cancers | Eddy Yang |
4:50 PM | Cases and Q&A |
3:45 PM – 5:15 PM
Impact of COVID-19 on Patient Care and Workforce – Update 2023
Moderator: Jonathan Irish
This session brings together national and international health system leaders and will discuss the impact of Covid-19 on our national and international health care systems. The session will discuss the immediate impact on patient care (surgery, medical, radiation, screening), the longer term impact on patient care (late stage presentation, survival impact) and discuss how the pandemic affected the health care provider. The session will conclude with what lessons were learned and potential solutions for the future.
At the conclusion of this session, participants will be able to:
- Articulate the variations in health system responses during the pandemic and how these responses impacted patient care.
- Integrate some of the lessons learned and processes implemented from the Covid-19 experience into health care delivery for the future.
- Plan for future pandemics and major disruptions in care in health care systems from the lessons learned from the Covid-19 pandemic.
3:45 PM | Introduction | Jonathan Irish |
3:50 PM | The Acute Response at ‘Ground Zero’ – Italy/Europe | Stefano Taboni |
4:02 PM | The Acute Response at ‘Ground Zero’ – New York | Vikas Mehta |
4:14 PM | The Long Term Impact on Patient Care – Canada | Jonathan Irish |
4:26 PM | The Long Term Impact on Patient Care – USA | Deepa Danan |
4:38 PM | The Long Term Impact on Health Systems and Lessons Learned | Michael Kupferman |
4:50 PM | The Long Term Impact on Health Systems and Lessons Learned | Bevan Yueh |
5:05 PM | Q&A |
3:45 PM – 5:15 PM
Tumor Board Topics: Indications for Adjuvant Therapy
Moderator: Eric Genden
We will use a series of challenging cases and audience participation to discuss the indications for adjuvant therapy and implications of adjuvant therapy on outcomes and quality of life.
At the conclusion of this session, participants will be able to:
- Articulate the indications and contraindications for implementing adjuvant therapy.
- Identify patients that would benefit from standard adjuvant therapy or would be beTter served in a clinical trial.
- Predict the impact of adjuvant therapy on treatment outcomes and quality of life.
3:45 PM | What is the State of Adjuvant Therapy for the Management of Head and Neck Malignancy? | Eric Genden |
3:55 PM | The Role of Adjuvant Radiotherapy in the Management of Oral/Oropharynx Cancer | James Caudell |
4:15 PM | The Role of Adjuvant Therapy Following Salvage Surgery | Ara Chalian |
4:35 PM | The Role of Adjuvant Systemic Therapy and Immunotherapy in the Management of Oral/Oropharynx Cancer | Nabil Saba |
4:55 PM | Case Presentations and Discussion |
3:45 PM – 5:15 PM
Video Session I
Moderators: Gina Jefferson and Sandeep Samant
We will use a case presentation format with videos to discuss the management of cancer of the oropharynx and parapharyngeal space tumors. The discussion will include management of the unknown primary, tonsil and base of tongue cancer resections, prevention of complications, approach to parapharyngeal space tumors, and robot-assisted neck dissection.
At the conclusion of this session, participants will be able to:
- Employ surgical strategies for management of the unknown primary tumors.
- Distinguish the nuances of different robotic platforms for approach to oropharynx tumors.
- Assess the benefits and drawbacks of robot-assisted neck dissection.
3:45 PM | Approach to Unknown Primary | Enver Ozer |
4:05 PM | Robotic Management of Tonsil Cancer | Jeffrey Houlton |
4:20 PM | Xi set up for TORS, Parapharyngeal Space Tumor Resection | Andrew Holcomb |
4:35 PM | Prevention and Management of Vascular Injury | Steve Kim |
4:40 PM | Robot-Assisted Neck Dissection | Sandeep Samant |
5:10 PM | Q&A |
3:45 PM – 5:15 PM
Proferred Papers Sessions
11 – Nasopharynx (2)
12 – Oropharynx (1)
13 – Immunotherapy (1)
14 – Functional (1)
15 – Salivary (1)
3:45 PM – 5:15 PM
Equity, Inclusion, and the Challenges Facing Underrepresented Surgeons: From Fairness to Effectiveness
Supported by a generous educational grant from Intuitive Surgical
Moderator: Trinita Cannon
We will use a moderated panel discussion to address issues regarding equity & inclusivity in pay, opportunities for leadership and career advancement as it pertains to the Head and Neck Surgeon work force.
At the conclusion of this session, participants will be able to:
- Recognize that despite some advances in diversity, equity, and inclusion, we are seeing uneven results in terms of representation for non-majority individuals in medicine.
- Highlight and discuss measures for gender neutral hiring and promotion practices within academic medicine.
- Define best practices for implementing Gender Salary Equity and Increase awareness of the current gaps in LGBTQIA academic medicine.
3:45 PM | Equity, Inclusion, and the Challenges Facing Underrepresented Surgeons: From Fairness to Effectiveness | Trinita Cannon |
3:50 PM | Principles & Approaches for Inclusion of LGBTQIA in Academia and AHNS | Ellie Maghami |
4:07 PM | Principles for Guiding Gender Equity in Faculty Hiring and Promotion Supporting Diversity and Inclusion | Greg Kempl |
4:24 PM | Effective Methods Used to Ensure Gender Salary Equity | Anna Pou |
4:41 PM | Framework for Advancing Equity in Academic Medicine and Science | Francisco Civantos |
4:58 PM | Q&A |
5:15 PM – 6:45 PM
Welcome Reception (Exhibit Hall Opening)
The AHNS gratefully acknowledges Merck Healthcare KGaA for support of the Welcome Reception.
5:15 pm – 6:45 pm
Additional Support Acknowledgement
6:30 PM – 8:00 PM
Room 516C
Session: Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer – NON-CME
Presenters: Stephen Lai, MD; John De Almeida, MD; Clare Schilling, MD; Steven Chang, MD
Supported by an educational grant from Cardinal Health Nuclear & Precision Health Solutions
Appetizers, beer, wine and beverages provided
7:30 AM – 8:30 AM
Jatin Shah Symposium: Circulating DNA – Clinical Applications
Moderator: Robert Ferris
We will present short talks related to the general state of the field of circulating tumor DNA ( ctDNA for HPV+ and HPV-), its use for disease monitoring in Recurrent/Metastatic settings, applications to deintensification for HPV+ patients, and emerging approaches.
At the conclusion of this session, participants will be able to:
- Learn the potential application of ctDNA for recurrence monitoring in non-HPV and HPV-associated HNSCC.
- Explain the potential application of HPV+ ctDNA in minimal residual disease for adjuvant therapy deintensification.
- Understand current and emerging ctDNA approaches and technologies which will impact patient care in the near future.
7:30 AM | Introduction | Robert Ferris |
7:35 AM | ctDNA for Disease Monitoring in HNSCC | Christine Chung |
7:50 AM | ctDNA for De-intensification in HPV+HNSCC | Nishant Agrawal |
8:05 AM | Next Generation Liquid Biopsy Approaches | Daniel Faden |
8:20 AM | Q&A |
8:30 AM – 9:15 AM
Global Medicine Keynote
Keynote: Pankaj Chaturvedi
Introduction: Eben Rosenthal
9:15 AM – 10:00 AM
Presidential Address
Introduction: Eben Rosenthal
Keynote: Brian Burkey
10:00 AM – 10:30 AM
Keynote Address
Introduction: Eben Rosenthal
Keynote: Rebecca Richards-Kortum
10:30 AM – 11:00 AM
Break in Exhibit Hall
Room 220BCDE
11:00 AM – 12:30 PM
Best of Basic Science (non CME)
Moderator: Joseph Califano
Key thought leaders in translational application of basic investigation will share insights into head and neck cancer biology. These insights will be directly related to clinical application in therapy, detection, and advanced surgical practice.
At the conclusion of this session, participants will be able to:
- Understand the diverse means by which molecular and immunologic alterations in head and neck cancer provide opportunities for therapeutic and diagnostic intervention.
- Explore the complexity and interaction of genomic, transcriptional, and phenotypic changes in head and neck carcinogenesis and novel understanding of head and neck cancer biology.
- Define opportunities for novel therapeutic, diagnostic, and imaging targeting based on basic and translational investigation into head and neck cancer biology.
11:00 AM | Myb-NFIB Fusion in Adenoid Cystic Carcinoma: Evidence for a Mechanistic Role | Patrick Ha |
11:15 AM | Expanding Role for IAP Antagonists with Radiotherapy for Head and Neck Cancers | Nicole Schmitt |
11:30 AM | The Optimus Story: How New FDA Guidance on Drug Dosing Will Require New Techniques in Molecular Imaging | Wendell Yarbrough |
11:45 AM | A Novel Approach to Measuring Molecular Residual Disease in Head and Neck Cancer | Jose Zevallos |
12:00 PM | CASP8 Inactivation is an Initiating Event in Oral Carcinogenesis | John Sunwoo |
12:15 PM | Q&A |
11:00 AM – 12:30 PM
Global Outreach – How Do We Make an Impact?
Moderator: James Netterville
This session will include speakers who will share their experience with successful Medical outreach programs in low and middle income regions. The speakers have a combined experience of over 80 years of service in medical outreach. Each speaker will share from their experience, lessons learned, to help the participant to avoid mistakes and benefit from the successful outcomes of these various outreach efforts.
At the conclusion of this session, participants will be able to:
- Create better skills to understand productive medical outreach in low and middle income regions.
- Prioritize various options for creating a successful medical outreach program.
- Have access to senior mentors that can successfully advise on setting up successful programs.
11:00 AM | If We Get the Basics Right – Best Results Will Follow: The Use of RT QA to Improve Nasopharynx Cancer Outcomes in Low-Income Countries | June Corry |
11:15 AM | The Critical Role of Trainees in Global Outreach | Mark Prince |
11:30 AM | Challenges and Unintended Results, Good and Bad | Gayle Woodson |
11:45 AM | The Mutual Benefit of Global Partnership: Clinical Research Observations from Cameroon | Wayne Koch |
12:00 PM | Expanding American Engineering Research to Build Capacity in Low and Middle Income Regions | Rebecca Richards-Kortum |
12:15 PM | Q&A |
11:00 AM – 12:30 PM
Oral Cavity Panel – Early Stage
Moderator: Rodney Taylor
There are several key issues in the management of early oral cancer that continue to be actively discussed including primary site and neck management, risk factors for developing the disease and rehabilitation, among others. This panel of experts will provide their perspective on these topics and others in a series of presentations and through discussion with the participants.
At the conclusion of this session, participants will be able to:
- Recognize the changing profile of risk factors for oral cancer.
- Diagram how to manage a patient who presents with an inadequately resected early oral cancer.
- Illustrate what the challenges are in the rehabilitation of patients with early oral cancer following surgical management.
11:00 AM | Introduction and Overview | Rodney Taylor |
11:05 AM | The Growing Cohort of Patients Without Traditional Risk Factors for Oral Cancer – What’s Going On? | Rodney Taylor |
11:17 AM | Decision Making in Difficult Clinical Scenarios at the Primary Site and in Determining Who Needs an Elective Neck Dissection – When and What? | Ashok Shenoy |
11:29 AM | Imaging Contributions to Staging and Mapping of Early Oral Cavity Cancer | Deborah Shatzkes |
11:41 AM | The Holy Grail of Personalized Surgical Decision-Making: Developing an Evidence-Based Approach to Surgical Margins and Head and Neck Reconstruction | Sidharth Puram |
11:53 AM | Excisional Biopsy and Excisions and Subsequent Management in Questionable Margins | Sheng-Po Hao |
12:05 PM | Best Practice Speech Pathology Management of Early Oral Cancer | Liz Ward |
12:17 PM | Q&A |
11:00 AM – 12:30 PM
Proferred Papers Session
15 – Cancer Biology (3)
16 – Endocrine (2)
17 – Reconstruction (2)
18 – Oral Cavity (2)
11:00 AM – 12:30 PM
Update and Discussion of Robotic Trials
Moderator: John de Almeida
We will discuss recently completed, ongoing, and future robotic surgery trials in head and neck. We will discuss patient selection and treatment decision making based on trial evidence.
At the conclusion of this session, participants will be able to:
- Appraise recent evidence of trials for robotic surgery.
- Identify good candidates for surgical intervention with robotic surgery.
- Create a management plan and discuss opportunities for de-intensification of treatment with robotic surgery for oropharyngeal cancer and unknown primary cancers.
11:00 AM | Introduction | John de Almeida |
11:05 AM | ECOG 3311 | Umamaheswar Duvvuri |
11:15 AM | ORATOR 1 and 2 | Anthony Nichols |
11:25 AM | Clinical Trials of the Trans-hairline Approach for Robotic Surgery of Head and Neck | Tsung-Lin Yang |
11:35 AM | Future Robotic Surgery Trial Concepts | Chris Holsinger |
11:45 AM | Unknown Primary | John de Almeida |
11:55 AM | Case Discussion | |
12:20 PM | Q&A |
12:30 PM – 2:00 PM
New Member Induction Ceremony
12:30 PM – 2:00 PM
Industry Symposia
Room 516C
Presented by EMD Serono
Presenters: Robert Ferris, MD; Robert Haddad, MD; Nancy Lee, MD
Title: Evolving Treatment Paradigm for Patients With LA SCCHN
Room 518ABC
Presented by Answers in CME
Presenters: Emily Ruiz, MD, MPH; Neil Gross, MD, FACS
Title: A Window of Opportunity to Enhance Earlier Use of Immunotherapies in Nonmelanoma Skin Cancers: Moving from Advanced to Neoadjuvant Settings
2:00 PM – 3:30 PM
Global Education
Moderator: Merry Sebelik
Four presentations by head and neck surgeons relating to improving head and neck cancer care in low resource settings.
At the conclusion of this session, participants will be able to:
- Understand the potential for remote head and neck ultrasound training and project-focused team training in cancer quality improvement.
- Understand the challenges relating to head and neck reconstruction in lower and middle income settings.
- Understand manpower needs and training in lower and middle income countries.
2:00 PM | Introduction | Merry Sebelik |
2:05 PM | Challenges in Reconstruction and Rehabilitation in Low Resource Settings | Pankaj Chaturvedi |
2:17 PM | Developing Resources – Manpower Training | Maxwell Kligerman |
2:29 PM | Ultrasound Education Across the Globe: How Head & Neck Surgeons Can Learn POCUS | Merry Sebelik |
2:41 PM | The PAICE Project: Mentored Remote Project-Focused Team Training in Cancer Quality Improvement | Karl Lorenz |
2:53 PM | Q&A |
2:00 PM – 3:30 PM
Management of Skull Base Tumors
Moderator: Ehab Hanna
This session will focus on contemporary approaches of diagnosis and management of sinonasal and skull base tumors. This will include the diagnosis of newly described sinonasal tumors, the role of endoscopic resection of advanced sinonasal cancers, and the emerging role of neoajduvant systemic therapy. The session will also cover recent (and ongoing) clinical trials related to locally advanced nasopharyngeal cancer as well as consolidation to the primary site in the setting of metastatic disease, and the role of surgery in management of recurrent/persistent disease. Finally the session will also describe the outcomes of skull base surgical resections in the pediatric population.
At the conclusion of this session, participants will be able to:
- Discuss findings from several recent clinical trials in nasopharyngeal cancer, and assess the role of surgery in salvage of recurrent and persistent disease.
- Evaluate the role of endoscopic surgery in the management of advanced sinonasal cancer with skull base involvement and the outcomes of skull base surgery in the pediatric population.
- Discriminate DEK::AFF2 fusion papillary SCC from similar tumors such as benign sinonasal papillomas, HPV-associated papillary SCC, and SCC arising from sinonasal papilloma.
2:00 PM | Introduction | Ehab Hanna |
2:05 PM | The Role of Endoscopic Transnasal Surgery in the Treatment of Sinonasal Cancers Involving the Anterior Skull Base | Stefano Taboni |
2:19 PM | Neoadjuvant Systemic Therapy for Sinonasal Tumors | Deborah Wong |
2:33 PM | Recent Clinical Trials for Locally Advanced Nasopharyngeal Cancer | Heath Skinner |
2:47 PM | Management of Recurrent/Persistent Nasopharyngeal Carcinoma | Ricardo Carrau |
3:01 PM | Skull Base Tumor Surgery in the Pediatric Population | Dan Fliss |
3:15 PM | Q&A |
2:00 PM – 3:30 PM
Surgical Clinical Trials – Ongoing Innovations
Moderator: Erich Sturgis
We will discuss the process of designing, implementing, and running surgical clinical trials. We will have perspectives on different types of surgical trial concepts from a medical oncologist as well as from 2 surgical oncologists on their personal experiences with the process.
At the conclusion of this session, participants will be able to:
- Articulate the role surgical oncologists should play in clinical trial design and implementation.
- Recognize the complexity of the process to properly conduct a clinical trial and integrate this knowledge into future plans they may have.
- Prioritize clinical trial participation for their patients wherever and whenever possible.
2:00 PM | Introduction and Overview | Erich Sturgis |
2:10 PM | Achieving Successful Collaborations in Different Types Of Surgical Trials: A Medical Oncology Perspective | Lillian Siu |
2:30 PM | Perspective of a UK Surgical Trialist Before and After Brexit | Clare Schilling |
2:50 PM | Lessons Learned: Developing and Leading a Cooperative Group Head and Neck Surgery Trial in North America | Stephen Lai |
3:10 PM | Q&A |
2:00 PM – 3:30 PM
Video Session II: “We have the Technology” – Endoscopic Advances in Head and Neck Surgery
Moderator: Jonathan Russell
We will use a video demonstration format to highlight the role of endoscopes at decreasing morbidity in head and neck surgery. Panelists will demonstrate surgical techniques and maneuvers that are possible due to endoscopes, and highlight potential future areas for advancement.
At the conclusion of this session, participants will be able to:
- Describe the current state of the art with remote access endoscopic techniques in head and neck surgery.
- Offer patients endoscopic alternatives (or referrals to providers who can offer these techniques) to common head and neck surgical pathology.
- Anticipate future advances in surgical endoscopy.
Panelists: Mark Jameson, Eric Bissada, Harishanker Jeyarajan
2:00 PM | Introduction | Jonathan Russell |
2:10 PM | TORS – Better Than Open? | Eric Genden |
2:20 PM | Panel Discussion | |
2:30 PM | TORS – One Port Better Than Three? | Uttam Sinha |
2:40 PM | Panel Discussion | |
2:50 PM | Can I Even Do It Without a Camera? | Chen-Chi Wang |
3:00 PM | Panel Discussion | |
3:10 PM | Parathyroid Autofluorescence | Jason Hunt |
3:20 PM | Panel Discussion |
2:00 PM – 3:30 PM
Proferred Papers Sessions
1 9 – Radiation (2)
20 – Imaging (2)
21 – Immunotherapy (2)
22 – Oropharynx (2)
3:30 PM – 4:00 PM
Break in Exhibit Hall
Room 220BCDE
4:00 PM – 5:30 PM
Neo-adjuvant Immunotherapy
Moderator: Ravindra Uppaluri
We will review current knowledge and future directions in integration of immunotherapy for surgical management of head and cancers including practical considerations in the multidisciplinary setting. We will highlight how these studies can illuminate biomarkers and biology of response and resistance.
At the conclusion of this session, participants will be able to:
- Describe recent advances and future directions in integration of neoadjuvant immunotherapy prior to surgery in head and neck cancers.
- Understand practical peri-operative considerations in the coordination of these therapies around surgery.
- Demonstrate an understanding of correlative biomarkers and biologic insights from neoadjuvant immunotherapy studies.
4:00 PM | Current/ Future State of Neoadjuvant Immunotherapy | Christine Chung |
4:15 PM | Practical Considerations: The Jefferson Experience | Adam Luginbuhl |
4:30 PM | Neoadjuvant Immunoradiotherapy Prior to Surgery: Towards a New Paradigm in the Management of Locally Advanced Head and Neck Cancer | R. Bryan Bell |
4:45 PM | Changing the Paradigm: Cutaneous SCCA and Neoadjuvant IO | Renata Ferraroto |
5:00 PM | Biologic Insights from Neoadjuvant Studies | Sidharth Puram |
5:15 PM | Q&A |
4:00 PM – 5:30 PM
Palliative Care – Opportunities
Moderator: Christine Gourin
Palliative care is a recognized key component of multidisciplinary cancer care: however, worldwide, less than 20% of patients who would benefit from palliative care receive it, and the majority of patients referred for palliative care are referred at the end of life. This panel will address the impact of the incorporation of palliative care into multidisciplinary head and neck cancer evaluation and treatment on patient outcomes, and discuss opportunities to increase palliative care access and education.
At the conclusion of this session, participants will be able to:
- Articulate the value of palliative care in the care of the head and neck cancer patient.
- Recognize the importance of integrating palliative care into the multidisciplinary team.
- Identify opportunities for formal training in palliative care.
4:00 PM | An Overview of the Palliative Care Landscape in Head and Neck Cancer Care | Christine Gourin |
4:20 PM | The Development of Surgical Palliative Care as a Specialty | Susan McCammon |
4:40 PM | Improving and Measuring the Quality of Palliative Support for Head and Neck Cancer Patients | Karl Lorenz |
5:00 PM | Developing a Subspecialty Palliative Care Clinic | Anna Gersten |
5:20 PM | Q&A |
4:00 PM – 5:30 PM
Tumor Board Topics: Management of the (Un)resectable
Moderator: Jason Newman
In this session, we will explore the management options for patients with disease that is considered on the border of ‘resectable’. Has this definition changed as we have more advanced operative technology, and also more advanced non-surgical ways to manage and cure patients with head and neck cancers.
At the conclusion of this session, participants will be able to:
- Identify the multiple options for management of advanced oropharynx cancer.
- Compare the various treatment options for patients with advanced cutaneous carcinoma.
- Integrate multi-disciplinary management into decision making for advanced head and neck cancer.
4:00 PM | Advanced Cutaneous Carcinoma-How Far Should We Go? | Jennifer Cracchiolo |
4:15 PM | Indications and contraindications in TORS | Gregory Weinstein |
4:30 PM | Making Unresectable, Resectable in Oropharyngeal Cancer | Nader Sadeghi |
4:45 PM | Tumor Board | Barton Branstetter Keith Casper Jennifer Cracchiolo Gregory Weinstein Nader Sadeghi |
4:00 PM – 5:30 PM
Tumor Board Topics: Salivary Gland
Moderator: Daniel Deschler
We will use a series of case presentations to discuss and explore critical and controversial topics in the combined modality management of salivary gland cancers. Specific attention will address issues and advances in pathologic diagnosis and pre-treatment imaging, extent of surgery, role of adjuvant treatment, current approaches to reconstruction and follow-up recommendations.
At the conclusion of this session, participants will be able to:
- Integrate advances in pathologic diagnosis and staging into treatment planning for salivary gland cancers.
- Implement evolving principles defining the extent of surgery in multidisciplinary management of salivary gland cancers.
- Employ appropriate reconstructive techniques at the time of primary treatment and in the secondary setting after salivary gland cancer treatment.
4:40 PM | Introduction and Case Presentations | Daniel Deschler |
Panelists | David Eisele Kelly Malloy Min-Sik Kim Bhishamjit Chera Nicole Chau |
4:00 PM – 5:30 PM
Proferred Papers Sessions
23 – Hypopharynx (1)
24 – Oral Cavity (3)
25 – Functional (2)
26 – Education (1)
5:30 PM – 7:00 PM
Fellowship Information Session
7:30 AM – 9:00 AM
Milton J. Dance Symposium: Improving Outcomes Through Collaboration and Discovery for HNSCC
Moderator: Bevan Yueh
This Symposium will highlight the newest approaches and technologies with potential to improve functional outcomes and quality of life after treatment for H&N cancer. We will focus our discussion on how to consider trade-offs between costs of new technologies, potential sacrifices in survival, and better functional and patient-reported outcomes.
At the conclusion of this session, participants will be able to:
- Describe newest developments in peri-operative and intra-operative molecular imaging.
- Convey the impact of recent and future RCTs on functional outcomes and quality of life.
- Appreciate the dilemma of simultaneously achieving lower costs, better survival, and improved functional outcomes.
7:30 AM | Introduction | Bevan Yueh |
7:40 AM | Short and Long Term Reduction of Toxicities in Targeted Therapies | Eben Rosenthal |
7:55 AM | Clinical Trial Approaches in Radiotherapy to Reduce Toxicity and Improve QOL | Quynh-Thu Le |
8:10 AM | Treatment Optimization for Early Stage HPV-Associated Oropharynx Cancer | Barbara Burtness |
8:25 AM | Next-generation Clinical Trials of Transoral H&N Surgery: From PATHOS to Precision PORT | Chris Holsinger |
8:40 AM | Q&A |
9:00 AM – 10:00 AM
Hayes Martin Lecture Introduction
Introduction: Brian Burkey
Keynote: Theodoros Teknos
10:00 AM – 10:30 AM
Break in Exhibit Hall
Room 220BCDE
10:30 AM – 12:00 PM
Immunotherapy as Combined Modality Therapy (non CME)
Moderator: Joseph Curry
This session will review therapeutic strategies to enhance the efficacy of anti-PD1 immune checkpoint inhibition. The panel will review combining anti-PD1 therapy with surgery, radiation and other immune and tumor modulating therapies.
At the conclusion of this session, participants will be able to:
- Articulate current strategies for enhancing aPD1 immune therapy response.
- Evaluate current data on therapeutic emerging strategies for immunotherapy.
- Relate the potential benefits for patients receiving immunotherapy in combination with other approaches.
10:30 AM | Combining Radiation with Immunotherapy to Enhance Efficacy | Aaron Popovtzer |
10:45 AM | Anti-PD1 Therapy In Combination with Surgery: Neoadjuvant Approaches to Surgery | Dan Zandberg |
11:00 AM | Novel Immunotherapy Combinations to Enhance Anti-PD1 Therapy Responses | Andrew Sikora |
11:15 AM | Cutting Edge Technologies and Approaches to Optimize Anti-PD1 Therapy in HNSCC | Young Kim |
11:30 AM | Anti-PD1 Therapies in the Management of CSCC and BCC in the Head and Neck | Matt Fury |
11:45 AM | Q&A |
10:30 AM – 12:00 PM
Improving Quality in Head and Neck Cancer
Moderator: Bert O’Malley
We will use a presentation and discussion format to introduce the concept of a ‘Quality Agenda’ and how collaboration among our specialty societies can drive quality and outcome improvement in our field of head and neck oncology. With detailed examples, we will discuss quality measurement strategies, outline key components of infrastructure that are needed to achieve quality, and introduce ways to improve outcomes ranging from palliative care initiatives to quality assurance programs for head and neck cancer clinical trials.
At the conclusion of this session, participants will be able to:
- Demonstrate an understanding of the concept of a Quality Agenda.
- Identify key infrastructure required to support quality improvement efforts.
- Evaluate the benefits of palliative care initiates and clinical trials quality assurance programs in driving outcomes improvement for head and neck cancer patients.
10:30 AM | Introduction | Bert O’Malley |
10:35 AM | Safety vs Quality? | Bert O’Malley |
10:40 AM | Establishing a Quality Agenda for Head and Neck Cancer Patients | Brian Nussenbaum |
10:55 AM | How the AHNS Can Lead Quality Improvement: Lessons from the Value and Quality Care Committee | Vasu Divi |
11:10 AM | Embedded Palliative Care in the Head and Neck Cancer Clinic | Miriam O’Leary |
11:25 AM | Surgical Quality Assurance in Head and Neck Cancer Trials | Christian Simon |
11:40 AM | Q&A |
10:30 AM – 12:00 PM
Oral Cavity Panel: Advanced Stage
Moderator: Peter Dziegielewski
A multi-disciplinary case management approach will be used to discuss challenging advanced oral cavity cancers. Decision making, treatment options, outcomes and controversies will be presented.
At the conclusion of this session, participants will be able to:
- Integrate a multis-disciplinary counsel to improve patient centered treatment planning.
- Convey expected outcomes of advanced oral cancer treatment.
- Develop survivorship plans for patients with significant functional deficits after advanced oral cavity cancer treatment.
10:30 AM | Extent of Resection / Margins | Steven Cannady |
10:45 AM | Adjuvant Radiation | Sharon Spencer |
11:00 AM | Liquid Biopsy / Recurrence Prevention | Uttam Sinha |
11:15 AM | Speech and Swallowing Rehabilitation | Rosemary Martino |
11:30 AM | Reconstructive Challenges | Peter Dziegielewski |
11:45 AM | Q&A |
10:30 AM – 12:00 PM
Salvage Surgery in 2023
Moderator: Sarah Rohde
We will review the patient prognosticators in salvage surgery followed by a case based review and discussion of site specific considerations. The ethical considerations in salvage surgery will be identified and explored.
At the conclusion of this session, participants will be able to:
- Convey patient prognosticators in salvage surgery and recognize the importance of multi-disciplinary decision making.
- Distinguish the site specific considerations in salvage surgery.
- Recognize ethical considerations surrounding salvage surgery.
10:30 AM | Introduction and Patient Prognosticators in Salvage Surgery | Sarah Rohde |
10:48 AM | Oropharyngeal Salvage Surgery | Jeremy Richmon |
11:06 AM | Laryngeal & Hypopharyngeal Salvage Surgery | Richard Smith |
11:24 AM | Oral Cavity Salvage Surgery | Marita Teng |
11:42 AM | Ethical Considerations in Salvage Surgery | Andrew Shuman |
10:30 AM – 12:00 PM
Proferred Papers Sessions
27 – Hypopharnyx (2)
28 – Imaging (3)
29 – Endocrine (3)
30 – Reconstruction (3)
12:30 pm – 2:00 pm
Industry Symposium
Lunch provided
Room 516C
Presented by Exelexis
Presenters: Siddharth Sheth, DO, MPH
Title: An Exelixis Product for the Clinical Management of Appropriate Patients in Differentiated Thyroid Cancer
1:30 PM – 3:00 PM
Complexities in Staging Head and Neck Cancer
Moderator: William Lydiatt
We will use presentations to outline the key issues of staging head and neck cancer as the 9th Edition of the AJCC and UICC manuals are being developed. Case presentations will illustrate some of these complexities.
At the conclusion of this session, participants will be able to:
- Compare and contrast the key issues necessary to create an equitable and predictive staging system.
- Identify the radiographic and physical examination complexities of staging HNC.
- Understand the importance of nodal, biologic, non-anatomic and other data that may be utilized in staging.
1:30 PM | Overview of Staging Changes for the Eighth Edition | William Lydiatt |
1:44 PM | Role of Radiology in Staging Specific Questions | Barton Branstetter |
1:58 PM | Importance of Physical Examination in Staging | Trevor Hackman |
2:12 PM | The Role of Non-anatomic Factors in Staging | Barbara Wollenberg |
2:26 PM | The Cyclical Influence of Staging on Treatment Paradigms | Snehal Patel |
2:38 PM | Bringing it all Home: Cases That Illustrate Concepts | Dimitrios Colevas |
1:30 PM – 3:00 PM
Controversies in Early-Stage Thyroid Cancer
Moderator: Louise Davies
Does a small tall cell cancer need a total thyroidectomy, and what about contralateral nodules in papillary microcancers? Come hear experts present and discuss their commonly encountered but difficult scenarios: learn updated evidence, pearls for approaching the thought process and tips for communicating the issues clearly and efficiently to patients.
At the conclusion of this session, participants will be able to:
- Convey current evidence around options for patients with commonly encountered but difficult early-stage thyroid cancer scenarios.
- Distinguish which controversies are related to issues around patient preferences and those that are related to issues around medical evidence, to assist in discussions with patients.
- Articulate communication pearls that can help foster satisfying and efficient discussions with patients as they consider their options.
1:30 PM | Introduction | Louise Davies |
1:35 PM | Is Lobectomy Enough for Early Stage Tall Cell Cancer? | Ian Ganly |
1:50 PM | Choosing Extent of Surgery When There are Contralateral Nodules | Joseph Scharpf |
2:05 PM | What is the Downside of Lobectomy for all Papillary Cancers that Don’t Have Metastases? | Babak Givi |
2:20 PM | How Important is Macroscopic Nodal Disease in Young People? | Paul O’Neill |
2:35 PM | Active Surveillance or Surgery for Early Papillary Cancers | Roberto Lima |
2:50 PM | Q&A |
1:30 PM – 3:00 PM
Laryngeal Cancer – Late-Stage Controversies
Moderator: D. Gregory Farwell
World experts in multidisciplinary head and neck oncologic care will discuss contemporary management of advanced laryngeal cancer. We will use case-based scenarios to demonstrate optimal personalized approaches to these tumors.
At the conclusion of this session, participants will be able to:
- Apply current evidence for optimal oncologic treatment for advanced stage laryngeal cancer.
- Predict which patients are good functional candidates for non-surgical primary treatment for advanced stage laryngeal cancer.
- Recognize disease-specific and patient-specific variables that will inform personalized treatment approaches.
1:30 PM | Session Introduction | D. Gregory Farwell |
1:32 PM | Key Surgical Pearls | Jeffrey Liu |
1:37 PM | Key Radiation Oncology Pearls | Houda Bahig |
1:42 PM | Key Medical Oncology Pearls | Dan Zandberg |
1:47 PM | Key Perioperative Pearls | Kenneth Byrd |
1:52 PM | Key Functional Predictor Pearls | Liza Blumenfeld |
1:57 PM | Case Based Discussion |
1:30 PM – 3:00 PM
Video Session III: State of the Art Surgical Techniques and Innovation
Moderator: Matthew Old
We will use a case-based hybrid video format to highlight innovative approaches and state of the art surgical techniques to common and uncommon head and neck pathology.
At the conclusion of this session, participants will be able to:
- Recognize the different techniques to approach common and uncommon head and neck pathology.
- Recognize the importance of innovation in head and neck surgery.
- Formulate unique treatment plans for uncommon tumors.
1:30 PM | Introduction | Matthew Old |
1:35 PM | Approaches to the Parapharyngeal Space and Resection of Paragangliomas | James Netterville |
1:50 PM | Resection and Management of Vagal Neurofibroma | Anna Pou |
2:05 PM | Flap Reconstruction and Rehabilitation for Transoral Robotic-Assisted Surgery | Fred Baik |
2:20 PM | Robotic Parathyroidectomy Through the Trans-Hairline Approach | Tsung-Lin Yang |
2:35 PM | Transoral Video Laryngoscopic Surgery for Laryngopharyngeal Cancer | Koji Araki |
2:50 PM | Q&A |
1:30 PM – 3:00 PM
Proferred Papers Sessions
31 – Cancer Biology (4)
32 – Oropharynx (4)
33 – Salivary (2)
34 – Immunotherapy (3)
3:30 PM – 5:00 PM
Controversial Topics in Thyroid Management
Moderator: Jeffrey Bumpous
We will discuss an evidence-based, practice guideline optimized approach to the surgical management of well-differentiated thyroid cancer, as well as best practices in the diagnosis and management of the compressive thyroid goiter. We will also appraise the role of advanced intraoperative technologies in the contemporary performance of thyroid and parathyroid surgery.
At the conclusion of this session, participants will be able to:
- Determine the extent of treatment necessary for well-differentiated thyroid cancer based on clinical and biomarker risk assessment.
- Determine the best approach for management of substernal thyroid goiters.
- Discuss the rationale and cost-effective use of advanced surgical technologies in thyroid surgery.
3:30 PM | Evidence-Based, Practice Guideline Optimized Approach to the Surgical Management of Well-Differentiated Thyroid Cancer | Ellie Maghami |
3:50 PM | Best Practices in the Diagnosis and Management of the Compressive Thyroid Goiter | David Shonka |
4:10 PM | The Role of Advanced Intraoperative Technologies in the Contemporary Performance of Thyroid and Parathyroid Surgery | Erivelto Volpi |
4:30 PM | Thyroid Surgical Cases | |
4:50 PM | Q&A |
3:30 PM – 4:45 PM
Highlights from the Korean Head and Neck Society Symposium: The Cutting Edges – Minimally Invasive and Hidden Scar Surgery in Head and Neck
Moderators: Kwang Hyun Kim and Kwang Jae Cho
We will present the cases and their associated video-clips to show and discuss about remote access or trans-oral surgery for head and neck cancer using endoscopy or robot to minimize surgical morbidity and postoperative scar.
At the conclusion of this session, participants will be able to:
- Understand minimally invasive and hidden scar surgery is a dedicated procedure to extirpate the tumor completely with high magnification, as well as to minimize surgical morbidity and postoperative scar.
- Discuss the advantages and disadvantages of minimally invasive and hidden scar surgery in comparison with conventional procedures.
- Prepare and conduct minimally invasive and hidden scar surgery.
3:30 PM | Remote Access “Scarless” Thyroidectomy | Jun Ook Park |
3:45 PM | Robotic and Endoscopic Surgery for Salivary Gland Tumor | Chul Ho Kim |
4:00 PM | Robotic Surgery for Para-pharyngeal Space Tumor and Retro-pharyngeal Lymph Node | Yoon Woo Koh |
4:15 PM | Latissimus Dorsi and Scapular Tip Flap Harvest with Axillary Approach | Soon Hyun Ahn |
4:30 PM | Trans-oral Video-laryngoscopic Surgery for Laryngo-hypopharyngeal Cancer | Il Seok Park |
3:30 PM – 5:00 PM
Surgical Innovation in Imaging
Moderator: Maie St John
We will use a panel presentation format to discuss state of the art innovations in surgical imaging and discuss collaborative pathways forward for multiple techniques in surgical imaging.
At the conclusion of this session, participants will be able to:
- Articulate state of the art innovations in surgical imaging.
- Identify collaborative pathways forward for multiple techniques in surgical imaging.
- Recognize surgical imaging techniques that can be used in their own cases for optimal patient outcomes.
3:30 PM | Precision Surgery: New Frontiers in Head and Neck Cancer | Maie St. John |
3:43 PM | AI-supported NBI – Current State and Future Perspectives | Christian Betz |
3:56 PM | Image Guided Oral Diagnosis Using Confocal Laser Endomicroscopy | Camile Farah |
4:09 PM | Image Guided Surgery Using Fluorescent Tracers | Max Witjes |
4:22 PM | Intraoperative Nerve-Specific Fluorescence Imaging | Ryan Orosco |
4:35 PM | Nanoparticle Theranostics for Head and Neck Cancer Patients | Nidal Muhanna |
4:48 PM | Q&A |
3:30 PM – 5:00 PM
What Data is There to Support De-escalation?
Moderator: Quynh-Thu Le
We will be using a panel format to discuss the different approaches to treatment de-escalation in good risk HPV-related oropharyngeal cancers. Risks and benefits of each approach based on available data will be presented.
At the conclusion of this session, participants will be able to:
- Identify the appropriate patient group for treatment de-escalation.
- Differentiate the different approaches to treatment de-escalation.
- Articulate the pros and cons to each approach.
3:30 PM | The Role of Surgery and Lessons Learned from De-escalation Studies so Far | Hisham Mehanna |
3:50 PM | Radiation De-escalation – Given the Current Evidence, What Should We Be Doing Right Now? | June Corry |
4:10 PM | The Role of Systemic Therapy in Treatment De-escalation | Saad Khan |
4:30 PM | Case Presentation and Discussion | |
4:50 PM | Q&A |
3:30 PM – 5:00 PM
Proferred Papers Sessions
35 – Radiation (3)
36 – Oral Cavity (4)
37 – Functional (3)
38 – Education (2)
5:15 PM – 6:15 PM
Robotic Shark Tank (non-CME)
Chair: Jeremy Richmon, MD
This non-CME presentation will bring together four promising emergent robotic companies and a panel of innovators, investors and skeptics in an informal and fun Shark Tank format immediately before the Presidential Reception. There will be light appetizers and drinks available at the conclusion of the session to allow for networking and interface with audience members. At the conclusion of the hour, the panel of judges will select the “winners.”
JUDGES
Chris Holsinger, MD, Professor of Head and Neck Surgery, Stanford University
Dion Madsen, B.Comm, CFA, Amplitude Ventures
James Netterville, MD, Professor of Otolaryngology and Director of the Division of Head and Neck Surgery, Vanderbilt University
Kathryn M. Van Able, MD, Mayo Clinic, Rochester
ROBOTIC COMPETITORS
CMR
Galen Robotics
Medical Microinstruments
7:00 PM – 10:00 PM
Presidents’ Reception at the Windsor Ballrooms
7:30 AM – 8:15 AM
Awards Ceremony
8:15 AM – 8:30 AM
Closing Comments
8:30 AM – 9:15 AM
Christopher O’Brien Lecture
Introduction: Eben Rosenthal
Keynote: Hisham Mehanna
9:30 AM – 11:00 AM
The Origin of AHNS: 25th Anniversary Forum
Moderator: Melonie Nance
We will present a narrative history of the merger of the SHNS and ASHNS in 1998 and how this resulted in the current AHNS. This will include first hand narrative of these events from senior leaders who were involved at that time, including the past Presidents of the SHNS and ASHNS at the time of the merger.
At the conclusion of this session, participants will be able to:
- Understand how the American Head and Neck Society was formed.
- Understand the perspective of each of two different Surgical specialties who perform Head & Neck Surgery.
- Recognize the contributions of senior leaders in establishing the AHNS 25 years ago.
9:30 AM | Background of Two Head & Neck Societies | Melonie Nance |
9:45 AM | SHNS Perspective with Q&A | Ashok Shaha |
10:05 AM | ASHNS Perspective with Q&A | KT Robbins |
10:25 AM | The Significance of the New Society: AHNS | Eugene Myers |
10:45 AM | Past, Present and Future of AHNS | Joseph Goodman |
9:30 AM – 11:00 AM
Do We have Consensus on Surgical Margins?
Moderator: Michael Topf
Although head and neck oncologists agree that surgical margin status is a critical prognostic factor, consensus on many surgical margin topics remains challenging. In this panel, speakers will discuss areas of controversy and general agreement on surgical margins, and will also explore future directions and novel approaches to surgical margin analysis.
At the conclusion of this session, participants will be able to:
- Identify controversies in surgical margins for mucosal squamous cell carcinoma.
- Interpret the literature on margin analysis, frozen sections, and management of a positive margin.
- Evaluate future directions and novel approaches to margin analysis including 3D scanning of surgical specimens and fluorescence-guided sampling.
9:30 AM | Introduction / Overview of Surgical Margins | Michael Topf |
9:40 AM | Surgical Margin Considerations in HPV-Positive Oropharyngeal Cancer | Vinidh Paleri |
9:50 AM | What Happens in the Pathology Suite? | Joseph Valentino |
10:00 AM | Specimen-based vs Tumor-bed Approach to Margin Analysis | Stephen Kang |
10:10 AM | Are Frozen Sections Evidence Based? | Pankaj Chaturvedi |
10:20 AM | Management of the Positive Margin | Stephen Kang |
10:25 AM | Shifting the Intraoperative Communication Paradigm with 3D Scanning | Margaret Brandwein-Weber |
10:40 AM | The Sentinel Margin | Naoki Nishio |
10:45 AM | REIMS (iKnife) | Vinidh Paleri |
10:50 AM | Q&A |
9:30 AM – 11:00 AM
European Commitment to Survivorship Through Quality and Innovation
Moderator: Terry Day
In line with the conference theme ‘Welcoming Back the World: Striving for Innovation, Quality, Compassion, and Collegiality’, the session will highlight some innovative examples of EHNS-led projects that aim to improve outcomes for people with head and neck cancer (HNC).
At the conclusion of this session, participants will be able to:
- Demonstrate the positive global outcomes achieved by the Make Sense campaign since 2013 and value of implementing awareness campaigns in the HNC setting.
- Provide a detailed overview of the planning, implementation and outcomes of a country- wide HNC screening program.
- Communicate findings from the ‘Oncokompas’ trial that evaluated the efficacy of a fully automated eHealth application to support cancer survivors in their self-management.
9:30 AM | Introduction and Overview | Terry Day |
9:35 AM | The Value of Awareness Campaigns in the HNC Setting: An Evaluation of the Make Sense Campaign | Rene Leemans |
9:55 AM | Planning, Implementation and Outcomes from a National HNC Screening Program: A Case Series from Poland | Wojciech Golusinski |
10:15 AM | Self-management in HNC Survivors | Irma Verdonck-de Leeuw |
10:45 AM | Q&A |
9:30 AM – 11:00 AM
Proferred Papers Sessions
39 – Biology (5)
40 – Reconstruction (4)
41 – Nasopharynx (2)
42 – Salivary (3)
43 – Hypopharynx (3)
11:00 AM – 12:30 PM
Cancer Screening (non CME)
Moderator: Heather Edwards
Through individual presentations followed by a Q&A period, we will explore issues in head and neck cancer screening and early detection including effective design and implementation of screening programs in different geographic, cultural and health system contexts, and evidence-based application of novel technologies.
At the conclusion of this session, participants will be able to:
- Understand effective design and implementation of successful screening programs in different geographic, cultural and health system contexts.
- Review established and novel technologies that have been applied to screening and early detection.
- Interpret clinical outcomes data regarding efficacy of technologies for screening and early detection, and consider potential applications to various practice models.
11:30 AM | National Screening Program In Taiwan for Oral Cancer | Chih-yen Chien |
11:42 AM | Narrow Band Imaging for the Detection of Early Laryngeal Cancer | Edward Damrose |
11:54 AM | Cancer Screening in Oral Premalignant Lesions | Carissa Thomas |
12:06 PM | Novel Technologies in Screening and Early Detection | Snehal Patel |
12:18 PM | Q&A |
11:00 AM – 12:30 PM
New Concepts in Management of NMSC
Moderator: Cecelia Schmalbach
We will utilize a combination of panel and case-based presentations to present recent advancements in the management of cutaneous squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. Focus will include the high risk immunosuppressed patient population, advances in immunotherapy, and related translational research.
At the conclusion of this session, participants will be able to:
- Define management strategies for high risk immunosuppressed cSCC patients.
- Identify the role of PD-1 inhibitors for NMSC (cSCC; BCC; Merkel Cell Ca).
- Identify challenges in cSCC data collection for research and ways to mitigate these barriers.
11:00 AM | Introduction/Objectives/Epidemiology | Cecelia Schmalbach |
11:05 AM | Contemporary Approaches to High Risk cSCC Patients | Cecelia Schmalbach |
11:20 AM | Immunotherapy: New Frontiers for of NMSC | Ilana Doweck |
11:40 AM | Managing the Burden of Disease and Interrogating the Molecular Landscape of cSCC | Bruce Ashford |
12:00 PM | Case Presentations | |
12:15 PM | Q&A |
11:00 AM – 12:30 PM
Video Session IV: Thyroid
Moderator: Mark Zafereo
The panelists will use video demonstration and discussion to illustrate new technologies and advanced techniques in thyroid surgery. Topics covered will include continuous nerve monitoring, infrared autofluorescence, medial to lateral thyroidectomy approach, and tracheal resection.
At the conclusion of this session, participants will be able to:
- Evaluate the technique and principles of neuromonitoring and how to utilize laryngeal adductor reflex neuromonitoring data during thyroid surgery to improve outcomes.
- Illustrate how NIRAF technology can be applied in thyroid surgery, including an understanding of common pitfalls and limitations.
- Understand advanced thyroid surgery techniques including medial to lateral thyroidectomy and tracheal resection.
11:00 AM | Introduction | Mark Zafereo |
11:05 AM | Continuous Laryngeal Adductor Reflex Monitoring During Thyroid Surgery | Erin Buczek |
11:20 AM | Medial to Lateral Approach to Thyroidectomy | Ameya Asarkar |
11:35 AM | Near-infrared Autofluorescence Technology in Thyroid Surgery | Amanda Silver-Karcioglu |
11:50 AM | Tracheal Resection for Thyroid Cancer | Mark Zafereo |
12:05 PM | Q&A |
11:00 AM – 12:30 PM
Proferred Papers Sessions
44 – Skin (2)
45 – Oral Cavity (5)
46 – Reconnstruction (5)
47 – Functional (4)
48 – Education (3)
Room 220 BCDE
Sunday, July 9
5:15 PM – 6:45 PM
Opening Reception
Monday, July 10
10:00 AM – 4:00 PM
Tuesday, July 11
10:00 AM – 4:00 PM
Confirmed list of exhibitors
ACERA SURGICAL
Ascendis Pharma
Atos Medical
Axogen
BioSyent Pharma
C2Dx, Inc.
Cardinal Health Medical Affairs
Cardinal Health Nuclear & Precision Health — LYMPHOSEEK(R)
Checkpoint Surgical
Checkpoint Surgical, Inc.
Cook Medical
CranioRehab
ECO Medical Technology (Nanjing) Co., Ltd.
EMD Serono
Exelixis
FLUOPTICS Part of Getinge
InHealth Technologies
Inomed, Inc.
Integra Lifesciences
Interpace Diagnostics
JAMA Network
KARL STORZ Endoscopy America, Inc.
KLS Martin Group
Medical Microinstruments
Medtronic
Merck & Co., Inc.
Naveris, Inc.
Rakuten Medical
Regeneron
Replimune
Stryker
THANC Foundation
True Angle
Vector Surgical
Veracyte, Inc.
Hands-On Learning
Room 220 BCDE
Sunday, July 9
5:15 PM – 6:45 PM
Opening Reception
Monday, July 10
10:00 AM – 4:00 PM
Tuesday, July 11
10:00 AM – 4:00 PM
CARDINAL HEALTH
Visit Cardinal Health’s Learning Center station to learn more about sentinel lymph node biopsy (SLNB) for head and neck cancers. Surgical experts and Medical Affairs personnel can answer questions, perform lymphatic mapping demos, share clinical trial information, and help identify what you need to start SLNB at your institution.
MMI – Medical Micro Instruments
Interested in learning about robotic microsurgery? Please visit MMI (Medical Microinstruments) in the Learning Center to gain knowledge of the Symani Surgical System and how it is currently being used in head and neck cancer applications. Our team will be available to discuss the system and provide hands-on demonstrations.
The Symani Surgical System is a CE marked (CE 0051) medical device and is approved in Australia by TGA for clinical use. Symani is not cleared or approved for clinical use in any other country.
Hands-On Learning
Room 522 ABC
Saturday, July 8
4:00 PM – 6:00 PM
Join the following companies for hands-on learning related to the pre-meeting courses while enjoying a wine and cheese reception.
The AHNS gratefully acknowledges Cook Medical for their support of the Expo Reception.
Company Related Course
Cook Medical Salivary
ECO Med Tech TORS/Robotics
Medtronic Endocrine
MMI TORS/Robotics
Naveris TORS
Sunday, July 9
12:15 PM – 1:45 PM
Lunch provided
Room 518ABC
Presented by Regeneron
Speaker: Badri G. Modi, MD
Title: Co-managing Patients with Advanced Basal Cell Carcinoma (aBCC) and Advanced Cutaneous Squamous Cell Carcinoma (aCSCC) in the Immunotherapy Era
Sunday, July 9
12:15 PM – 1:45 PM
Lunch provided
Room 519AB
Presented by Naveris
Presenters: Chris Holsinger, MD, FACS; Glenn Hanna, MD; Bisham Chera, MD
Topic: Detection of HPV-Driven OPSCC: Clinical Evidence of an Innovative Blood Test – Clinical Role of NavDx in Managing OPSCC
Sunday, July 9
6:30 PM – 8:00 PM
Appetizers, beer, wine and beverages provided
Room 516C
Supported by an educational grant from Cardinal Health Nuclear & Precision Health Solutions
Presenters: Stephen Lai, MD; John De Almeida, MD; Clare Schilling, MD; Steven Chang, MD
Topic: Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Monday, July 10
12:30 PM – 2:00 PM
Room 516C
Presented by EMD Serono
Presenters: Robert Ferris, MD; Robert Haddad, MD; Nancy Lee, MD
Title: Evolving Treatment Paradigm for Patients With LA SCCHN
Monday, July 10
12:30 pm – 2:00 pm
Lunch provided
Room 518ABC
Presented by Answers in CME
Presenters: Emily Ruiz, MD, MPH; Neil Gross, MD, FACS
Title: A Window of Opportunity to Enhance Earlier Use of Immunotherapies in Nonmelanoma Skin Cancers: Moving from Advanced to Neoadjuvant Settings
Tuesday, July 11
12:30 pm – 2:00 pm
Lunch provided
Room 516C
Presented by Exelexis
Presenters: TBA
Title: An Exelixis Product for the Clinical Management of Appropriate Patients in Differentiated Thyroid Cancer
Visibility Sponsors
GOLD
Naveris
SILVER
EMD Serono
BRONZE
Endo Quest Robotics
Educational Grant Supporters
PLATINUM
Intuitive Surgical
SILVER
Merck Sharp and Dohme
BRONZE
Cook Medical
Saturday Series
Symposium
12:30 PM
Welcome
Danny Enepekides
12:35 PM
An Update on the WHO Classification of Salivary Neoplasia
Felix Nguyen
12:50 PM
State of the Art Imaging for Salivary Gland Pathology
Eugene Yu
1:05 PM
Extracapsular Resection: The How, When, and Why
Vincent Vander Poorten
1:25 PM
Panel Discussion: Management of Benign Salivary Neoplasia
Moderator: Kiran Kakarala
Panelists: Vincent Vander Poorten, Carol Lewis, Marie-Jo Olivier, Davud Sirjani
2:10 PM
Q&A
2:20 PM
Break
2:30 PM
Extent of Surgery: Malignant Tumors of the Major Salivary Glands
Mirabelle Sajisevi
2:50 PM
Adjuvant Therapy: Radiation
Khalil Sultanem
3:10 PM
Novel Systemic Therapies for Salivary Gland Malignancy
Renata Ferraroto
3:30 PM
Break
3:40 PM
Panel: Management of Malignant Salivary Neoplasia
Moderator: Michael Hier
Panelists: Joel Davies, Larissa Sweeny, Eugene Yu, Mirabelle Sajisevi, Bruce Ashford, Irene Kim
4:20 PM
Q&A
10:00 AM
Devil in the Details: Patient Selection and Choosing patients for TORS
Moderator: Katie Van Abel
Panelists: Robert Brody, Brittany Barber, Ryan Jackson, Oluwafunmilola Okuyemi, Jeffrey Magnuson, Mirabelle Sajisevi
11:00 AM
Clinical Trials in Transoral Endoscopic H&N Surgery
Moderator: Philippe Gorphe
PATHOS – Progress
Mererid Evans
ECOG3311 – What Did We Learn? What has Changed?
Miriam Lango
MOSES – Unraveling the Unknown Primary
Vinidh Paleri
Trials for HPV-Negative Disease
Deepa Nair
ORATOR
Anthony Nichols
FIND
John de Almeida
12:05 PM
Lunch
1:00 PM
Training and Simulation v2.0
Moderator: Anne Kane
TORS Simulator
Baran Sumer
Novel Tech for TORS
Catherine Lumley
Advanced Educational Tools for TORS Using Immersive Technology
Jonathan Morris
1:35 PM
Minimizing Complications through Swallowing Rehabilitation – Pre and Post-Op Care
Moderator: Rosemary Martino
Pearls: Pre-HABILITATION for TORS
Carly Barbon
Pearls: Optimizing Post-Op Rehabilitation
Justin Roe
Panel Discussion: Case
Ryan Li
Panel Discussion: Case
Jo Patterson
Panelists: David Cognetti, Michael Topf
2:30 PM
Break
2:45 PM
To Ligate or Not? Management of Post-operative Bleeding Risk
Moderator: Meghan Turner
Panelists: Jeffrey Houlton, Jeffrey Jorgenson, Elizabeth Anne Nicolli, Georges Lawson, John Gleysteen
3:20 PM
Multidisciplinary Care of TORS Patients: Preop Selection, Post-op Adjuvant Tumor Board Case Presentations with the Multidisciplinary Team
Moderator: Will Ryan
Panelists: Eleni Rettig, Michael Topf, Scharukh Jalisi, Nancy Lee, Beth Beadle, Glenn Hanna, Asit Arora
The AHNS gratefully acknowledges a generous educational grant in support of this course from Intuitive Surgical.
This session is supported by a generous educational grant from Medtronic.
International Session on Autofluorescence and Fluorescent Angiography
9:00 AM
Introduction
Michael Singer
9:05 AM
Introduction and History of Autofluorescence Technology, Fluorescence vs. Autofluorescence
Michael Singer
9:10 AM
Conventional Approach to Parathyroid Preservation
David Terris
9:20 AM
Outcomes Regarding Hypoparathyroidism and the Future Regarding Treatment of Hyperparathyroidism
Amanda Silver-Karcioglu
9:30 AM
Surgical Technique Using Autofluorescence
Gregory Randolph
9:40 AM
Parathyroid Angiography and Vascular Anatomy of the Parathyroids
Fares Benmiloud
9:55 AM
Break
10:05 AM
Case Presentations
Moderators: Michael Singer, Fares Benmiloud
Panelists: David Shonka, Maie St. John, Amanda Silver-Karcioglu
Multidisciplinary Session: Advanced and/or Aggressive Thyroid Cancer – “New Hopes for Patients With Historically Limited Options”
11:00 AM
Introduction
Mark Zafereo
11:05 AM
Identification of Advanced Thyroid Cancer Populations, Molecular Markers and Genetic Testing
Joseph Scharpf
11:15 AM
History of Immunotherapy and Small Molecule Agents in Thyroid Cancer
Richard Harbison
11:25 AM
Surgical Options for Advanced Thyroid Cancers
Neil Tolley
11:35 AM
Neoadjuvant Chemo and Advanced Thyroid Cancers
Mark Zafereo
11:45 AM
Clinical Trial Results on Advanced Thyroid Cancer
Lori Wirth
12:00 PM
Break
1:10 PM
Case Presentations
Moderators: Mark Zafereo, Lori Wirth
Panelists: Michael Hier, Niel Tolley, Antoine Eskander, Ian Witterick
Radiofrequency Ablation
2:05 PM
Introduction
Jon Russell
2:10 PM
Ablation: Adoption of a New Technology in the Thyroid Surgery Space
Erivelto Volpi
2:20 PM
Available Ablative Technologies
Marika Russell
2:30 PM
Ablation of Benign Thyroid Lesions
Jon Russell
2:40 PM
Ablation of Thyroid Malignancies and Recurrences
Erivelto Volpi
2:55 PM
Break
3:05 PM
Tumor Board 1: Benign Lesions
Moderator: Jon Russell
Panelists: Lisa Caulley, Catherine Sinclair, Elizabeth Cottrill, Marco Mascarella
3:30 PM
Tumor Board 2: Malignant Lesions
Moderator: Jon Russell
Panelists: Jonathan Irish, Marika Russell, Keith Richardson, Erivelto Volpi
8:00 AM
Welcome and Introductions
Deepa Shah
8:15 AM
Post-operative Care in the Inpatient Setting
Christine Park
8:45 AM
Head and Neck Cancer Treatment Related Dysphagia
Tamara Wasserman
9:15 AM
Nuances of Working Up a H&N Patient
Jacqueline Dibble
9:45 AM
Head and Neck Radiology Cases
Stephanie Lam
10:15 AM
Break
10:30 AM
APP Practice in Head and Neck Surgery
Panelists: Beverly Garber, Arnaud Bewley, Martha Ryan, Mark El-Deiry, Katherine Mead, Matthew Old
11:15 AM
Diagnostic and Predictive Value / Thoughts for Utilization and Surveillance Tool
Michelle Ziebarth
11:30 AM
Enhanced Recovery After Surgery (ERAS) in Free Flap and Total Laryngectomy Patients
Amanda Selhorst
11:45 AM
Value of APP-performed Head & Neck Ultrasound
Trina Sheedy